rfhg_182504.1

Basic information about the TSS

---

TSS ID: rfhg_182504.1 Species: human Chr: chr16		Start: 28823351 End: 28823361 Strand: +
Source datasets	FANTOM5
Protocol	CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	-
Category:	-

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: U70671:57 GeneID: 11273 HGNC/MGI_ID: HGNC:31326 UniProt_ID: Nearer transcript ids and distances: ENST00000570200.5:-99 BC082760:-99 ENST00000562867.5:121 ENST00000564304.5:-256 BC144269:-256 BC136584:-256 ENST00000325215.10:-258 ENST00000382686.8:-258 ENST00000395547.6:-258 AJ317972:-258 AJ317971:-258 AJ317970:-258 AJ317973:-258 AJ317974:-258 BC068012:-275 ENST00000340394.12:-303 AK289981:-303 ENST00000563314.5:-316 ENST00000336783.9:-352 NM_001387203.1:-352 NM_001387199.1:-352 NM_001387187.1:-352 NM_001387202.1:-352 NM_001387185.1:-352 NM_001387179.1:-352 NM_001387188.1:-352 NM_001387186.1:-352 NM_001387180.1:-352 NM_001387204.1:-352 NM_148416.3:-352 NM_148415.3:-352 NM_001387195.1:-352 NM_001387198.1:-352 NM_001387196.1:-352 NM_001387177.1:-352 NM_001387175.1:-352 NM_001387176.1:-352 NM_001387174.1:-352 NM_145714.3:-352 NM_017492.4:-352 NM_001387167.1:-352 NM_001387168.1:-352 NM_148414.3:-352 NM_007245.4:-352 NM_001387191.1:-352 NM_001387192.1:-352 NM_001387194.1:-352 NM_001387173.1:-352 NM_001387184.1:-352 NM_001387183.1:-352 NM_001387178.1:-352 NM_001387200.1:-352 NM_001387197.1:-352 NM_001387190.1:-352 NM_001387189.1:-352 NM_001387193.1:-352 NM_001387170.1:-352 NM_001387169.1:-352 NM_001387182.1:-352 NM_001308230.2:-352 NM_001387166.1:-352 NM_001387172.1:-352 NM_001387181.1:-352 NM_001387171.1:-352 view more...

Gene_name: ataxin 2 like Gene_symbol: ATXN2L Gene_synonyms: A2D A2lp Gene_source: HGNC:31326

TATA-Box annotation

---

Distance to TSS:	308
Nearest PromoterID:	NM_007245
Entrez ID:	11273
Nearest Unigene:	Hs.460499
Nearest Refseq:	NM_007245
Nearest Ensembl:	ENSG00000168488
Gene Name:	ataxin 2 like
Gene Alias:	A2D|A2LG|A2LP|A2RP
Gene Type:	protein-coding
CpG%:	0.000000
GC%:	0.818182
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@ATXN2L p2@ATXN2L p3@ATXN2L p4@ATXN2L p5@ATXN2L p6@ATXN2L p7@ATXN2L
Sample		p1@ATXN2L	p2@ATXN2L	p3@ATXN2L	p4@ATXN2L	p5@ATXN2L	p6@ATXN2L	p7@ATXN2L
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	35.06	121.95	9.55	1.56	1.36	2.14	0.19
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	26.91	110.87	6.07	0.81	1.42	0.61	0.20
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	28.36	111.88	7.14	2.12	0.96	1.16	0.39
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	26.20	99.80	5.20	1.25	0.83	1.66	1.04
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	26.10	112.26	7.20	1.12	1.12	1.12	0.22
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	25.20	111.63	4.26	2.13	1.16	2.13	0.78
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	38.35	100.88	6.75	1.09	1.53	1.96	0.44
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	26.89	101.49	5.81	1.21	1.21	0.73	0.00
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	36.12	87.62	5.13	2.35	1.50	0.64	0.64
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	27.82	68.98	6.38	1.16	0.58	1.74	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	31.13	72.76	5.66	2.43	3.23	0.40	0.00
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	32.12	75.21	4.47	1.22	1.22	0.81	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	96.39	38.20	5.80	0.48	0.00	0.32	1.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	70.66	28.72	3.76	0.45	0.75	0.00	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	87.38	31.18	4.61	0.22	0.22	0.22	0.88
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	67.40	27.66	5.28	0.25	0.75	0.75	0.25
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	71.20	31.89	3.28	0.66	0.00	0.00	1.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	76.35	26.15	4.64	2.11	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	63.45	33.06	3.73	0.00	0.53	0.53	0.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	71.61	43.03	4.06	0.60	0.30	0.30	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	68.03	30.47	3.07	0.53	0.27	0.27	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	70.43	38.67	3.28	0.35	0.00	1.04	0.69
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	63.98	29.73	4.14	0.39	0.13	0.26	0.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	71.34	34.70	2.43	0.73	0.24	0.24	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	87.46	41.02	5.68	0.26	0.00	0.26	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	78.50	39.88	5.38	0.32	0.32	0.00	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	79.12	38.46	9.34	1.10	0.00	0.00	0.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	90.29	56.82	4.72	0.47	0.47	0.00	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	65.74	42.00	3.39	0.65	0.48	0.32	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	70.58	43.79	3.98	0.36	0.90	0.18	0.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	58.41	50.66	3.98	0.00	0.42	0.00	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	63.89	50.99	3.52	2.15	0.00	0.00	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	57.82	37.35	5.06	0.84	0.21	0.21	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	50.64	41.56	3.79	0.49	0.16	0.66	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	66.01	48.24	2.62	0.37	0.19	0.19	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	69.94	44.07	3.26	0.19	0.00	0.38	0.57
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	47.01	49.05	2.66	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	47.55	40.10	4.63	0.20	0.40	0.60	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	46.73	38.89	2.43	0.27	0.54	0.00	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	41.29	38.41	2.16	0.00	0.00	0.00	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	41.17	45.88	2.59	0.47	0.47	0.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	43.04	37.18	2.20	0.29	0.29	0.15	0.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	51.67	47.03	5.48	0.00	0.84	0.42	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	55.07	47.03	2.45	0.52	0.17	0.35	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	47.98	44.57	2.41	0.60	0.40	0.20	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	49.55	49.55	2.56	0.00	0.00	0.23	0.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	52.06	48.22	2.88	0.24	0.24	0.48	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	49.77	50.07	2.38	0.60	0.60	0.30	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	64.15	52.18	2.87	0.24	0.24	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	60.05	56.62	3.03	0.61	0.00	0.20	0.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	56.77	45.50	3.69	0.61	0.20	0.61	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	73.38	55.37	3.78	0.44	0.22	0.44	0.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	69.96	13.99	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	42.23	29.45	4.97	0.35	0.35	0.00	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	42.09	27.84	3.98	0.33	0.00	0.00	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	75.50	82.22	2.52	1.68	0.00	0.84	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	47.30	50.52	3.21	0.00	0.92	0.00	0.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	79.73	33.38	1.94	0.65	1.30	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	65.52	32.12	2.25	0.64	0.32	0.00	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	75.75	92.10	5.34	1.26	0.63	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	33.84	29.61	0.71	0.00	0.00	0.00	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	42.62	22.99	1.12	0.56	0.00	0.00	0.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	222.12	110.66	4.78	2.39	0.80	1.59	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	94.46	64.56	2.72	0.34	0.00	0.00	1.02
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	91.95	45.16	5.85	2.27	0.65	0.00	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	75.97	29.11	2.84	1.06	0.00	0.00	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	48.49	48.49	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	55.28	31.59	7.90	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	48.26	15.60	7.80	0.49	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	45.12	12.89	2.98	0.50	0.00	0.00	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	47.38	19.23	3.28	0.94	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	108.96	28.15	7.62	0.99	0.33	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	73.62	17.63	3.71	1.86	0.00	0.00	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	65.43	11.01	4.59	0.61	0.31	0.00	0.31
Adipocyte - breast, donor1	11376-118A8	19.32	19.64	3.48	0.32	0.63	0.00	0.32
Adipocyte - breast, donor2	11327-117E4	25.83	26.79	0.80	0.16	0.48	0.32	0.00
Adipocyte - omental, donor1	11473-119C6	24.30	21.88	3.44	1.40	0.51	0.25	0.25
Adipocyte - omental, donor2	11474-119C7	14.95	41.86	2.99	0.75	0.00	0.00	0.75
Adipocyte - omental, donor3	11475-119C8	23.44	41.20	1.34	0.67	0.33	0.00	0.67
Adipocyte - perirenal, donor1	11476-119C9	17.86	35.73	1.91	0.00	0.64	0.00	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	8.80	53.88	0.00	1.10	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	22.13	26.19	0.45	0.90	0.00	0.45	3.16
Adipocyte - subcutaneous, donor3	11408-118E4	25.55	47.79	1.91	0.87	0.17	0.17	0.35
Adipocyte differentiation, day04, donor1	13019-139D4	51.44	32.07	2.54	0.39	0.20	0.00	1.37
Adipocyte differentiation, day04, donor2	13022-139D7	33.97	31.14	1.29	0.26	0.77	0.00	0.77
Adipocyte differentiation, day04, donor3	13025-139E1	43.49	42.93	2.23	0.84	0.28	0.00	0.56
Adipocyte differentiation, day04, donor4	13028-139E4	47.61	23.51	4.70	0.59	0.00	0.00	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	42.55	60.16	2.49	0.64	0.40	0.56	1.05
Adipocyte differentiation, day08, donor2	13023-139D8	45.83	39.70	1.61	1.29	0.97	0.32	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	30.39	31.99	0.00	1.60	0.00	0.00	1.60
Adipocyte differentiation, day08, donor4	13029-139E5	31.16	48.41	3.34	0.56	0.56	0.00	0.56
Adipocyte differentiation, day12, donor1	13021-139D6	19.96	101.89	1.25	0.83	0.42	0.00	0.42
Adipocyte differentiation, day12, donor2	13024-139D9	31.90	45.71	3.01	0.50	0.00	0.00	1.00
Adipocyte differentiation, day12, donor3	13027-139E3	18.00	50.40	1.64	0.00	0.00	0.33	0.33
Adipocyte differentiation, day12, donor4	13030-139E6	28.32	44.15	1.22	0.00	0.00	0.30	0.30
Alveolar Epithelial Cells, donor1	11510-119G7	43.32	31.16	3.76	0.66	0.44	0.22	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	74.23	124.43	3.94	1.43	1.43	0.00	0.36
Alveolar Epithelial Cells, donor3	11671-122G6	43.13	27.55	2.40	0.00	1.20	1.20	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	36.16	33.64	5.04	0.54	0.36	0.18	0.18
Amniotic Epithelial Cells, donor2	11613-122A2	58.57	56.90	1.67	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	46.84	61.22	6.37	0.21	0.21	0.21	0.41
Anulus Pulposus Cell, donor1	11248-116E6	22.08	11.33	2.63	0.23	0.11	0.00	0.11
Anulus Pulposus Cell, donor2	11463-119B5	37.47	17.14	5.14	0.73	0.24	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	16.62	37.74	0.45	0.00	0.00	0.00	0.45
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	19.10	34.73	4.78	0.00	0.00	0.43	0.43
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	10.70	64.21	2.14	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	19.13	36.17	2.39	0.30	0.60	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	21.50	41.73	2.53	1.26	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	13.20	30.36	0.66	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	17.87	36.39	2.60	0.00	0.32	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	17.48	26.21	0.97	0.00	0.49	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	12.47	40.98	2.38	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	13.18	39.92	3.39	0.38	0.38	0.00	0.38
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	17.42	32.66	1.45	0.00	0.73	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	12.54	33.85	1.25	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	13.84	20.59	2.97	0.00	0.66	0.16	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	12.28	36.85	1.36	0.00	1.36	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	14.17	30.16	1.66	0.15	0.15	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	18.22	36.43	1.07	0.00	0.54	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	21.54	30.23	2.65	0.00	0.19	0.19	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	16.04	37.42	2.41	0.53	0.27	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	13.66	44.87	1.95	0.00	0.98	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	13.60	26.04	1.99	0.00	0.33	0.33	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	18.01	34.82	1.20	0.00	1.20	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	17.70	49.56	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	15.95	26.42	1.54	0.17	0.51	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	0.00	46.14	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	14.08	26.70	2.43	0.49	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	19.35	31.11	1.90	0.00	0.00	0.38	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	13.33	47.24	1.21	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	17.10	31.92	1.71	0.00	0.57	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	14.11	23.73	2.14	0.21	0.00	0.21	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	21.68	34.07	2.06	0.00	1.03	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	11.73	34.25	0.47	0.47	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	18.01	26.37	0.96	0.00	0.00	0.32	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	16.41	42.81	1.43	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	19.89	29.83	3.51	0.00	0.58	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	17.76	32.21	2.11	0.00	0.30	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	22.57	49.90	1.19	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	11.70	40.18	2.03	0.00	0.51	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	28.78	30.82	2.29	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	21.60	33.67	2.54	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	18.56	35.82	1.29	0.43	0.00	0.43	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	16.09	25.61	1.91	0.64	0.42	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	12.18	33.06	2.03	0.00	0.29	0.29	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	29.29	39.68	1.89	0.00	0.94	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	16.44	22.04	1.53	0.17	0.17	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	11.58	44.01	2.32	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	16.90	52.81	2.11	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	14.79	26.16	0.86	0.00	0.21	0.21	0.21
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	10.23	42.12	1.20	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	15.31	34.99	2.19	0.00	0.00	1.46	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	15.63	28.28	2.07	0.23	0.46	0.00	0.23
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	5.10	40.80	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	11.95	24.66	1.27	0.51	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	15.28	27.25	2.06	0.21	0.41	0.41	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	18.05	34.58	0.61	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	17.21	23.42	2.39	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	15.30	20.84	1.55	0.00	0.22	0.22	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	10.68	38.14	0.00	1.53	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	13.29	41.54	1.66	0.00	0.00	0.00	0.55
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	13.24	23.83	1.32	0.00	0.53	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	12.36	43.25	1.82	0.36	0.00	0.00	0.00
Astrocyte - cerebellum, donor1	11500-119F6	40.65	51.09	9.46	1.97	0.74	0.12	0.00
Astrocyte - cerebellum, donor2	11580-120F5	68.98	77.71	7.02	3.59	1.37	0.00	0.00
Astrocyte - cerebellum, donor3	11661-122F5	41.11	44.05	2.94	1.89	0.42	0.42	0.21
Astrocyte - cerebral cortex, donor1	11235-116D2	40.78	38.00	2.09	0.70	0.00	0.70	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	55.81	78.30	4.21	0.65	0.81	0.81	0.49
Astrocyte - cerebral cortex, donor3	11392-118C6	58.77	83.83	2.83	1.04	0.00	0.00	0.45
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	104.94	85.21	18.46	3.21	1.26	1.72	0.46
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	102.98	100.48	16.16	3.76	1.00	1.38	1.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	86.14	102.99	14.79	4.21	0.91	0.80	0.57
Basophils, donor1	12241-129G9	54.66	14.12	14.12	1.31	1.05	0.00	0.52
Basophils, donor2	12242-129H1	80.10	25.98	19.84	2.53	1.80	0.00	0.36
Basophils, donor3	12243-129H2	75.70	17.05	9.70	1.18	1.62	0.29	0.29
Bronchial Epithelial Cell, donor1	11511-119G8	34.07	16.17	1.29	0.43	0.43	0.00	0.43
Bronchial Epithelial Cell, donor2	11591-120G7	98.29	57.15	10.06	1.37	1.37	0.46	0.46
Bronchial Epithelial Cell, donor3	11672-122G7	43.04	35.87	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	62.77	114.23	3.14	0.00	0.00	0.63	0.63
Bronchial Epithelial Cell, donor5	11457-119A8	88.79	56.98	4.16	1.46	1.46	0.21	0.42
Bronchial Epithelial Cell, donor6	11461-119B3	69.32	17.73	5.07	0.46	0.23	0.69	0.46
Bronchial Epithelial Cell, donor7	11769-123I5	39.77	11.52	3.24	0.00	0.00	0.00	0.00
Burkitt's lymphoma cell line:DAUDI	10422-106C8	89.45	43.39	22.47	1.75	7.01	1.03	0.31
Burkitt's lymphoma cell line:RAJI	10476-106I8	88.74	49.61	8.38	2.10	0.70	1.63	0.23
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	68.75	63.00	26.86	1.60	1.92	0.64	0.00
CD133+ stem cells - cord blood derived, pool1	12223-129E9	124.10	41.37	51.71	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	71.01	31.56	3.94	1.13	2.82	0.56	0.56
CD14+ Monocytes, donor2	11305-117B9	104.68	28.58	13.18	1.86	1.30	0.19	0.37
CD14+ Monocytes, donor3	11381-118B4	95.28	28.76	9.44	1.10	1.54	0.22	0.44
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	61.70	15.00	6.23	1.13	1.13	0.00	5.66
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	74.30	19.33	8.34	2.27	0.76	0.00	2.65
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	94.35	17.42	9.53	1.64	1.31	0.33	3.62
CD14+ monocytes - mock treated, donor1	11863-125A9	46.40	37.73	9.40	0.29	0.58	0.43	0.29
CD14+ monocytes - mock treated, donor2	11873-125C1	41.64	20.22	5.13	0.30	0.60	0.00	1.51
CD14+ monocytes - mock treated, donor3	11883-125D2	54.01	31.27	7.58	0.47	0.24	0.47	0.71
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	34.15	39.17	9.88	0.17	0.50	0.33	0.17
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	35.88	31.19	6.35	0.28	1.38	0.28	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	34.96	37.19	9.42	0.74	0.74	0.74	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	27.61	36.22	6.85	0.59	0.59	0.00	0.00
CD14+ monocytes - treated with BCG, donor2	11870-125B7	29.38	26.53	5.88	0.71	0.53	0.18	0.18
CD14+ monocytes - treated with BCG, donor3	11880-125C8	19.37	21.76	5.66	0.00	0.87	0.22	0.22
CD14+ monocytes - treated with Candida, donor1	11868-125B5	24.82	21.31	12.88	0.94	0.94	0.23	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	33.27	19.54	6.34	0.53	0.53	0.53	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	36.61	19.97	8.87	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	36.15	31.53	8.78	0.45	0.30	0.30	0.45
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	32.73	26.14	7.98	0.40	1.00	0.40	0.80
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	24.15	26.86	5.83	0.21	0.62	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	28.83	33.63	10.52	1.14	1.14	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	23.30	39.13	7.69	0.90	0.68	0.68	0.23
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	28.37	33.17	9.60	0.00	0.00	0.87	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	33.62	36.31	9.68	0.00	0.54	0.27	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	40.47	24.08	6.46	0.00	0.17	0.00	0.17
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	31.14	33.67	5.47	0.42	0.42	0.00	0.42
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	26.09	28.84	8.63	0.55	1.10	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	34.87	35.23	7.75	0.35	0.35	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	35.10	38.17	9.21	0.88	0.44	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	29.64	42.55	7.32	0.87	0.35	0.00	0.35
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	28.99	31.22	3.35	0.00	0.74	0.74	0.37
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	28.88	29.75	4.53	0.43	0.22	0.43	0.22
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	34.40	28.25	5.32	0.41	0.82	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	17.85	29.44	6.95	0.00	0.70	0.70	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	14.15	19.26	6.50	0.23	0.23	0.23	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	34.00	19.18	11.33	0.22	0.22	0.22	0.44
CD14+CD16+ Monocytes, donor2	11801-124D1	39.73	17.32	16.17	0.23	1.62	0.00	0.23
CD14+CD16+ Monocytes, donor3	11912-125G4	29.03	21.01	6.50	0.22	0.65	0.00	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	59.17	33.17	14.64	0.62	1.25	0.31	0.00
CD14+CD16- Monocytes, donor2	11799-124C8	50.12	27.42	11.70	0.70	0.87	0.00	0.00
CD14+CD16- Monocytes, donor3	11910-125G2	95.88	60.20	12.71	0.67	0.45	0.22	0.22
CD14-CD16+ Monocytes, donor1	11790-124B8	37.00	11.23	18.12	0.26	1.02	0.26	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	39.52	9.66	16.25	0.66	1.10	0.22	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	38.11	12.63	13.69	0.00	0.21	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	63.00	12.19	8.13	0.00	2.03	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	43.39	8.81	8.14	1.36	0.00	0.68	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	45.57	5.18	12.43	0.00	1.04	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	46.91	12.79	10.13	1.60	1.07	0.53	0.53
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	66.47	11.79	9.65	1.07	0.54	0.00	0.54
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	67.39	14.04	11.93	0.00	0.70	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	51.77	8.63	10.98	3.14	3.14	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	77.78	17.14	6.59	0.00	0.00	0.00	1.32
CD19+ B Cells, donor1	11544-120B5	149.59	36.16	14.79	3.29	2.47	0.00	2.47
CD19+ B Cells, donor2	11624-122B4	118.97	17.41	15.23	0.00	1.45	0.00	1.45
CD19+ B Cells, donor3	11705-123B4	129.24	28.78	14.64	4.54	2.02	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	86.06	60.20	2.42	0.40	0.00	0.40	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	59.92	36.35	5.99	0.40	0.00	0.00	0.00
CD34+ Progenitors, donor1	11545-120B6	51.21	24.10	34.14	0.00	3.01	1.00	0.00
CD34+ Progenitors, donor2	11625-122B5	43.26	34.27	30.34	4.49	4.49	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	46.22	46.97	16.91	2.25	0.38	0.38	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	59.08	59.30	14.43	0.45	0.90	0.90	0.23
CD4+ T Cells, donor1	11225-116C1	147.46	42.49	23.92	2.50	2.14	0.36	0.36
CD4+ T Cells, donor2	11306-117C1	132.27	41.64	25.11	1.84	5.51	0.00	1.22
CD4+ T Cells, donor3	11382-118B5	137.55	36.29	17.69	0.91	2.44	0.91	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	63.55	13.53	8.68	1.53	1.02	0.00	0.26
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	82.20	14.37	9.66	1.35	0.45	0.22	0.22
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	99.75	14.09	14.66	0.86	0.00	0.00	0.86
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	73.01	18.96	21.81	0.95	2.37	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	72.34	16.86	14.05	1.40	0.70	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	79.11	13.18	23.07	0.00	3.30	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	51.88	10.69	13.44	2.02	1.16	0.00	0.58
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	89.82	17.62	8.30	1.19	0.17	0.34	0.17
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	81.41	15.31	10.48	1.45	0.81	0.16	1.13
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	50.66	16.59	13.45	0.90	0.90	0.00	0.45
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	55.90	9.43	15.37	1.05	0.35	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	64.68	18.92	18.48	3.52	0.88	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	52.71	24.46	16.02	0.84	1.26	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	78.12	17.87	13.92	1.45	1.87	0.21	0.83
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	61.81	26.73	10.69	1.00	1.34	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	83.48	27.47	18.49	2.45	1.63	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	103.97	21.44	22.51	2.68	1.07	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	96.83	52.00	19.73	3.59	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	73.43	22.44	13.17	1.48	0.37	0.00	0.37
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	69.10	20.36	11.70	1.08	1.30	0.22	0.87
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	93.94	25.85	12.40	2.31	1.05	0.00	1.05
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	65.22	13.15	16.18	1.52	1.52	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	55.46	13.86	17.33	1.30	1.73	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	84.55	13.95	20.05	1.31	1.74	0.00	0.44
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	92.05	13.86	16.83	1.48	1.48	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	60.93	14.77	20.31	0.92	0.92	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	65.60	8.37	8.37	1.40	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	76.71	19.94	12.74	1.66	1.11	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	90.06	15.46	17.18	1.72	0.98	0.00	0.74
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	67.76	13.86	24.64	1.54	1.54	0.00	1.54
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	85.59	16.12	21.49	1.43	0.36	0.00	0.72
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	76.17	9.69	12.46	1.38	1.38	0.00	1.38
CD8+ T Cells, donor1	11226-116C2	106.40	30.12	19.32	2.62	3.60	0.33	0.98
CD8+ T Cells, donor2	11307-117C2	113.01	28.53	18.40	2.63	3.38	1.50	1.88
CD8+ T Cells, donor3	11383-118B6	148.72	38.38	20.20	4.29	4.80	0.25	1.26
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	41.29	21.79	36.47	3.67	2.52	0.23	0.00
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	35.71	20.37	42.42	5.75	4.31	0.00	0.48
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	29.00	16.69	43.77	4.38	3.28	0.55	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	28.22	26.42	38.43	5.10	3.60	0.30	0.30
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	41.52	23.52	35.28	6.72	0.72	0.48	0.48
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	38.66	22.28	41.38	4.55	2.50	0.00	0.23
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	38.02	26.94	39.33	5.87	2.39	0.00	0.22
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	31.32	33.69	47.64	3.68	4.47	0.26	0.26
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	31.66	32.36	46.43	4.92	3.52	0.70	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	26.57	30.49	36.83	3.02	2.42	0.00	0.30
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	37.48	25.56	36.89	5.23	4.94	0.58	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	32.77	37.83	37.03	4.00	2.93	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	52.53	24.51	34.14	9.63	4.38	1.31	0.88
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	56.02	15.03	43.72	7.74	5.92	0.46	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	94.73	36.55	47.74	8.95	3.73	2.98	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	47.18	25.21	44.30	7.92	3.60	0.36	0.36
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	33.95	25.89	36.25	4.32	3.74	0.86	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	41.25	23.57	41.95	3.06	2.83	0.24	0.71
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	26.94	26.30	52.61	6.97	6.02	0.00	0.63
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	31.37	26.14	48.60	7.38	3.69	0.00	0.92
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	23.40	27.57	47.13	4.17	5.45	0.32	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	37.86	25.24	32.51	3.44	3.06	0.38	0.38
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	27.59	23.65	41.38	3.94	5.12	0.79	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	31.77	28.74	36.31	3.03	4.54	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	53.00	33.72	55.40	9.64	3.21	2.41	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	79.04	27.98	49.66	6.99	4.90	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	74.13	33.06	60.11	17.03	4.01	1.00	0.00
Cardiac Myocyte, donor1	11525-119I4	107.84	9.14	1.83	0.00	1.83	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	21.25	30.14	1.48	0.49	0.00	0.00	0.00
Cardiac Myocyte, donor3	11686-122I3	18.73	8.31	1.37	0.21	0.00	0.11	0.00
Chondrocyte - de diff, donor1	11261-116G1	40.91	14.91	3.12	2.43	0.35	0.00	1.39
Chondrocyte - de diff, donor2	11338-117F6	24.52	8.88	2.49	0.71	0.36	0.00	1.07
Chondrocyte - de diff, donor3	11410-118E6	21.96	11.95	3.19	0.34	0.11	0.11	0.11
Chondrocyte - re diff, donor2	11339-117F7	25.96	17.01	2.69	2.69	0.90	0.00	0.00
Chondrocyte - re diff, donor3	11411-118E7	47.32	16.18	3.64	0.40	1.21	0.00	0.40
Ciliary Epithelial Cells, donor1	11242-116D9	42.46	38.67	7.92	2.52	0.34	0.23	0.23
Ciliary Epithelial Cells, donor2	11323-117D9	45.10	22.02	4.49	0.86	0.64	0.21	0.00
Ciliary Epithelial Cells, donor3	11399-118D4	44.60	39.91	6.46	1.68	0.53	0.00	0.27
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	104.63	40.99	8.34	2.57	1.38	0.64	1.65
Corneal Epithelial Cells, donor1	11526-119I5	44.13	16.25	5.49	0.88	0.44	0.00	0.22
Corneal Epithelial Cells, donor2	11606-120I4	26.16	53.47	2.28	0.00	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	52.92	23.26	4.35	0.51	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	44.25	15.68	9.41	1.16	1.65	0.00	0.17
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	47.00	17.03	6.94	0.63	1.58	0.00	0.63
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	20.70	3.45	10.35	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	40.06	14.15	6.91	1.40	0.86	0.22	0.65
Dendritic Cells - plasmacytoid, donor1	11228-116C4	85.07	35.53	11.27	1.71	1.02	0.00	0.68
Dendritic Cells - plasmacytoid, donor2	11309-117C4	71.16	23.50	11.75	0.65	2.61	0.65	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	63.88	40.65	16.45	0.97	2.90	0.00	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	60.70	32.69	7.67	1.17	1.00	0.17	0.50
Endothelial Cells - Aortic, donor1	11263-116G3	54.57	32.86	2.93	0.00	0.59	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	52.32	53.17	3.96	0.57	0.85	0.85	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	69.20	52.29	5.50	1.57	0.79	1.57	0.00
Endothelial Cells - Artery, donor1	11264-116G4	42.18	49.45	4.07	0.87	0.58	0.00	0.00
Endothelial Cells - Artery, donor2	11341-117F9	50.58	75.52	2.59	1.65	0.94	1.18	0.24
Endothelial Cells - Artery, donor3	11413-118E9	75.91	68.20	9.82	1.05	1.40	0.53	1.40
Endothelial Cells - Lymphatic, donor1	11236-116D3	39.68	15.29	4.43	0.66	0.66	0.22	0.22
Endothelial Cells - Lymphatic, donor2	11317-117D3	38.34	13.69	3.96	0.30	0.61	0.00	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	42.29	31.57	7.33	0.85	1.69	0.00	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	36.25	19.31	10.10	1.19	1.78	0.00	0.89
Endothelial Cells - Microvascular, donor2	11342-117G1	34.36	13.54	4.17	2.08	1.04	0.00	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	40.69	16.31	6.52	0.71	0.99	0.00	0.28
Endothelial Cells - Thoracic, donor1	11266-116G6	43.21	55.22	4.80	2.80	1.60	0.40	0.40
Endothelial Cells - Thoracic, donor2	11343-117G2	37.21	61.32	2.10	0.00	0.52	0.00	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	75.54	39.51	9.69	0.87	1.74	0.25	0.62
Endothelial Cells - Umbilical vein, donor2	11324-117E1	96.03	49.32	4.56	1.96	0.87	0.65	0.22
Endothelial Cells - Umbilical vein, donor3	11400-118D5	96.36	65.95	5.98	2.08	1.59	0.37	0.49
Endothelial Cells - Vein, donor1	11267-116G7	56.88	89.86	4.55	0.00	0.00	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	48.90	74.74	10.48	2.79	2.10	0.70	2.10
Endothelial Cells - Vein, donor3	11416-118F3	63.74	51.81	4.24	1.41	0.47	1.10	0.16
Eosinophils, donor1	12244-129H3	0.00	0.00	45.74	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	72.61	21.45	26.40	0.00	1.65	0.00	0.00
Eosinophils, donor3	12246-129H5	53.50	32.10	28.53	3.57	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	27.85	16.13	2.44	0.24	0.24	0.00	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	54.08	54.08	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	48.81	65.08	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	40.23	19.29	2.05	0.82	0.00	0.00	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	12.48	7.34	0.77	0.11	0.33	0.11	0.11
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	32.28	19.93	1.73	0.54	0.00	0.22	0.11
Fibroblast - Aortic Adventitial, donor1	11245-116E3	27.29	14.55	4.12	1.46	0.24	0.00	0.73
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	40.94	15.97	3.68	0.14	0.55	0.00	0.00
Fibroblast - Aortic Adventitial, donor2	11326-117E3	32.48	9.49	2.64	0.74	0.53	0.21	0.53
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	56.39	35.57	6.59	0.79	0.53	0.53	1.05
Fibroblast - Aortic Adventitial, donor3	11401-118D6	55.15	21.93	3.32	0.33	0.33	0.33	0.66
Fibroblast - Cardiac, donor1	11268-116G8	44.91	58.06	4.08	0.91	0.45	0.00	0.45
Fibroblast - Cardiac, donor2	11345-117G4	27.29	21.22	5.31	0.76	1.52	0.76	0.00
Fibroblast - Cardiac, donor3	11417-118F4	22.40	34.22	1.26	0.63	0.63	0.47	0.16
Fibroblast - Cardiac, donor4	11452-119A3	42.74	16.97	2.42	0.61	0.00	0.00	0.30
Fibroblast - Cardiac, donor5	11456-119A7	47.08	31.85	2.92	0.89	0.76	0.13	0.63
Fibroblast - Cardiac, donor6	11460-119B2	41.69	19.40	2.73	0.91	0.45	0.30	0.00
Fibroblast - Choroid Plexus, donor1	11492-119E7	30.68	43.55	2.68	2.68	0.40	0.27	0.00
Fibroblast - Choroid Plexus, donor2	11572-120E6	30.20	46.16	3.88	0.43	0.43	0.00	1.29
Fibroblast - Choroid Plexus, donor3	11653-122E6	43.94	54.20	2.93	1.46	1.46	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	107.48	37.36	12.69	2.08	0.46	0.69	0.46
Fibroblast - Conjunctival, donor3	11692-122I9	42.40	13.06	3.56	0.17	0.17	0.00	0.00
Fibroblast - Dermal, donor1	11269-116G9	29.35	18.31	3.05	0.70	0.47	0.00	0.70
Fibroblast - Dermal, donor2	11346-117G5	37.26	21.70	3.77	2.36	0.00	0.00	0.00
Fibroblast - Dermal, donor3	11418-118F5	30.71	25.39	2.30	0.73	0.12	0.24	0.36
Fibroblast - Dermal, donor4	11450-119A1	58.22	52.79	4.07	0.45	0.79	0.23	0.00
Fibroblast - Dermal, donor5	11454-119A5	75.71	87.75	5.06	1.22	0.35	0.52	0.17
Fibroblast - Dermal, donor6	11458-119A9	63.83	92.42	4.87	1.62	0.32	0.16	0.16
Fibroblast - Gingival, donor1	11237-116D4	36.23	7.08	3.96	0.42	0.21	0.21	0.42
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	48.99	19.65	2.62	0.26	0.26	0.00	1.31
Fibroblast - Gingival, donor2	11318-117D4	48.89	37.43	5.01	0.40	0.26	0.40	0.13
Fibroblast - Gingival, donor3	11394-118C8	61.20	11.60	3.67	0.58	0.29	0.19	0.48
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	31.17	8.31	4.16	1.04	1.04	0.00	1.04
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	37.36	22.03	1.94	0.70	0.18	0.18	0.00
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	57.68	48.17	6.39	1.09	0.31	0.31	0.31
Fibroblast - Gingival, donor6 (control)	11922-125H5	41.51	37.46	4.87	1.35	0.27	0.00	0.27
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	125.98	99.86	10.94	2.82	2.12	1.06	1.06
Fibroblast - Gingival, donor7 (control)	11924-125H7	46.07	45.63	1.90	0.88	1.02	0.00	0.44
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	36.13	45.54	3.41	0.68	0.55	0.41	0.00
Fibroblast - Gingival, donor8 (control)	11926-125H9	69.98	66.58	6.80	1.10	0.66	0.33	0.66
Fibroblast - Gingival, donor9 (control)	11927-125I1	48.13	22.01	2.79	1.61	0.44	0.29	0.44
Fibroblast - Lung, donor1	11270-116H1	70.69	46.22	4.08	1.36	0.00	0.00	1.36
Fibroblast - Lung, donor2	11347-117G6	59.69	34.32	4.48	2.98	0.00	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	44.32	36.09	2.95	0.63	0.00	0.21	0.00
Fibroblast - Lymphatic, donor1	11506-119G3	79.14	72.47	16.66	2.50	3.33	0.00	0.83
Fibroblast - Lymphatic, donor2	11586-120G2	51.75	53.15	1.40	0.00	1.40	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	36.10	21.83	4.20	0.00	0.56	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	82.01	55.21	7.71	1.22	0.41	0.41	1.22
Fibroblast - Mammary, donor2	11620-122A9	55.92	95.86	0.00	0.00	3.99	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	59.56	47.65	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	39.96	19.79	5.82	0.97	0.78	0.00	0.00
Fibroblast - Periodontal Ligament, donor2	11319-117D5	88.13	45.50	5.92	1.21	0.46	0.30	0.00
Fibroblast - Periodontal Ligament, donor3	11395-118C9	48.65	11.63	5.51	0.31	0.92	0.00	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	48.85	24.04	3.43	1.14	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	32.94	49.14	2.43	0.81	0.54	0.00	0.00
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	54.04	22.15	3.02	0.93	0.12	0.00	0.93
Fibroblast - Pulmonary Artery, donor1	11250-116E8	18.24	14.37	2.98	0.33	0.44	0.11	0.00
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	64.01	83.71	5.69	1.63	1.02	0.20	0.20
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	50.12	70.83	7.35	2.00	0.00	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	25.70	26.09	3.16	0.00	0.40	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	62.51	47.23	6.35	1.19	0.20	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	22.74	12.43	0.89	0.53	0.18	0.00	0.18
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	24.83	19.71	2.76	0.79	0.59	0.00	0.20
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	56.86	38.51	5.72	0.90	0.30	0.60	0.00
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	32.17	31.09	3.02	0.43	0.32	0.11	0.43
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	57.95	27.33	6.83	0.76	0.25	0.00	0.00
Fibroblast - skin normal, donor1	11553-120C5	24.78	9.84	2.63	0.00	0.49	0.00	0.00
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	68.77	36.09	9.22	1.00	0.40	0.40	0.20
Fibroblast - skin normal, donor2	11561-120D4	26.52	18.08	3.62	0.30	0.40	0.00	0.30
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	62.87	30.53	6.95	0.30	0.60	0.60	0.00
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	31.23	16.73	3.89	0.66	0.17	0.08	0.00
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	35.73	17.27	4.27	0.51	0.51	0.00	1.03
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	50.58	31.86	3.94	0.99	0.00	0.33	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	32.17	29.08	1.92	0.53	0.11	0.00	0.21
Fibroblast - skin walker warburg, donor1	11554-120C6	27.16	31.04	3.71	1.01	0.34	0.17	0.00
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	24.62	24.15	0.78	0.00	0.00	0.00	0.00
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	22.16	66.48	0.00	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	85.41	40.96	4.36	1.74	0.00	0.00	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	26.87	10.40	3.64	0.35	0.87	0.17	0.00
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	31.23	10.93	3.64	0.00	1.30	0.52	0.52
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	51.61	20.19	2.81	1.28	0.26	0.00	0.51
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	56.65	102.58	17.61	0.77	3.06	4.59	2.30
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	38.28	97.62	19.78	1.91	3.19	7.02	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	78.73	79.30	3.99	1.14	0.00	6.56	1.43
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	178.69	158.84	22.89	4.14	1.38	6.89	3.86
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	127.86	102.06	22.38	4.34	1.60	3.42	1.14
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	99.86	91.93	9.31	2.18	1.19	5.75	0.59
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	178.43	141.95	26.70	5.55	1.85	4.23	5.02
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	122.31	95.89	23.48	1.30	1.63	2.28	0.98
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	58.82	113.65	8.40	0.44	1.77	11.50	0.88
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	47.20	56.53	10.32	0.99	1.13	5.09	0.71
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	56.52	50.49	11.58	1.60	1.48	5.30	0.99
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	41.64	41.37	11.01	2.15	1.07	5.64	0.81
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	43.49	48.07	4.71	2.23	0.74	1.24	0.37
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	46.65	49.97	5.26	1.66	0.97	1.80	0.28
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	33.14	45.34	2.64	0.20	0.61	2.03	0.20
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	37.88	44.49	5.25	0.23	0.68	1.14	0.23
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	46.46	37.74	5.23	2.37	0.75	0.62	1.12
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	68.63	37.16	3.50	0.66	0.22	1.31	0.44
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	35.46	64.71	7.09	1.18	0.00	1.48	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	50.23	71.53	6.99	2.07	0.48	1.59	0.64
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	49.38	42.90	4.47	1.34	0.67	2.46	0.45
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	47.18	69.36	5.24	1.21	0.81	1.21	0.20
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	34.61	67.35	5.43	0.85	0.34	1.19	0.85
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	57.28	55.60	10.73	1.86	0.89	2.13	1.15
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	80.23	81.37	11.55	2.60	1.04	1.35	0.62
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	51.57	107.59	8.20	1.02	1.54	1.02	0.68
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	54.77	70.60	6.09	0.55	0.44	0.66	0.66
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	47.67	52.41	7.07	1.41	0.75	1.83	1.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	36.96	58.80	7.15	2.25	0.61	0.41	0.61
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	42.09	50.96	5.78	0.62	1.24	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	53.61	62.37	7.84	1.61	0.92	0.92	1.50
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	46.86	57.37	4.34	0.50	1.83	1.00	0.33
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	44.09	46.95	4.85	1.76	0.66	0.22	1.10
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	49.69	57.07	5.66	1.35	0.61	0.49	0.74
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	46.03	68.89	4.54	0.49	0.16	1.62	0.81
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	55.48	59.65	5.45	1.28	0.64	1.28	0.96
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	41.03	44.06	5.12	0.85	0.95	1.04	0.95
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	43.18	44.13	5.06	1.27	0.63	0.32	0.63
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	34.97	61.12	4.87	0.30	0.61	1.82	0.91
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	40.56	50.39	5.12	0.84	0.52	0.21	1.46
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	44.57	45.67	6.15	0.88	0.00	0.00	1.32
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	38.15	54.43	7.29	1.40	0.28	0.84	0.56
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	40.18	41.02	5.37	1.39	0.83	0.56	1.02
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	25.67	40.38	3.48	0.80	1.07	0.80	0.80
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	37.79	40.09	4.90	0.46	0.00	1.07	0.15
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	27.59	48.19	3.11	0.78	0.65	0.65	0.65
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	37.41	43.37	1.08	1.63	0.27	0.54	0.81
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	32.63	59.36	3.32	0.74	0.18	0.55	0.18
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	38.38	53.51	2.85	0.66	0.44	0.88	0.44
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	89.26	119.01	6.94	0.00	0.00	0.99	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	33.11	48.02	3.17	0.79	0.79	0.26	0.40
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	32.89	42.37	3.83	0.40	0.00	0.40	0.20
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	94.80	71.67	15.50	0.25	2.03	1.27	1.52
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	41.80	60.71	11.74	1.79	1.99	7.56	0.60
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	54.08	67.02	11.86	1.23	2.16	8.32	0.77
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	57.90	90.02	11.46	0.41	2.05	9.62	2.25
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	29.42	52.89	7.20	0.63	1.88	5.01	0.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	28.54	39.56	8.48	1.41	0.57	3.67	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	44.74	45.66	7.38	0.92	0.92	1.38	2.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	42.07	56.92	12.37	2.47	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	37.13	46.42	10.83	3.48	3.09	2.32	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	32.09	57.76	11.23	0.00	1.60	3.21	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	45.21	69.55	6.96	1.74	5.22	1.74	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	30.92	54.68	6.84	1.63	0.00	4.23	0.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	49.00	52.30	7.00	1.65	1.24	4.12	0.82
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	56.65	113.30	16.66	3.33	3.33	10.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	38.59	58.17	3.92	1.40	0.28	0.84	1.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	40.20	50.01	3.27	0.65	0.65	0.98	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	62.07	88.92	7.55	0.00	0.00	0.00	0.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	42.30	59.16	4.13	0.64	0.32	2.86	1.27
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	37.02	50.61	4.42	1.36	0.68	0.34	1.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	29.23	75.17	4.18	0.00	0.00	0.00	2.09
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	47.53	65.29	1.72	2.29	1.15	2.29	1.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	31.37	48.54	1.18	1.18	0.30	1.48	0.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	30.49	64.38	1.69	1.69	0.00	1.69	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	34.38	74.56	4.97	2.49	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	36.13	75.71	6.44	1.38	0.00	2.30	0.23
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	26.34	126.44	0.00	0.00	5.27	10.54	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	31.91	52.28	3.08	1.54	0.77	1.54	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	28.69	56.39	3.26	0.65	0.00	1.63	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	38.79	74.91	1.34	1.34	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	40.45	44.69	3.08	1.16	0.77	0.39	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	46.56	127.35	7.53	1.71	2.05	4.45	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	69.57	64.60	7.45	0.00	0.00	0.00	2.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	57.57	59.45	2.36	2.36	0.47	1.89	1.42
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	44.66	44.06	1.21	1.21	0.00	1.81	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	57.48	75.79	2.54	4.07	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	56.64	58.63	4.39	3.19	0.80	1.60	0.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	55.26	51.31	4.44	0.99	0.49	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	49.58	67.29	0.00	1.18	1.18	1.18	1.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	41.42	51.93	4.08	1.75	0.58	0.58	1.17
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	57.05	54.42	1.32	0.88	1.32	0.44	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	54.25	79.68	5.09	0.00	0.00	0.85	1.70
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	37.01	45.96	1.79	0.60	0.60	0.60	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	30.09	49.98	2.91	1.94	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	31.96	47.93	1.14	1.14	1.14	0.00	2.28
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	27.03	46.57	4.57	1.25	0.83	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	66.34	181.04	4.50	1.12	0.00	0.00	1.12
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	23.15	17.44	5.39	0.00	0.63	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	9.19	10.44	3.76	0.00	0.84	0.00	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	27.50	65.68	3.71	0.58	0.23	0.46	0.00
Hep-2 cells mock treated, biol_rep2	11899-125E9	28.02	73.94	2.19	0.84	0.68	1.01	0.00
Hep-2 cells mock treated, biol_rep3	11900-125F1	31.17	58.47	2.73	0.91	0.23	0.68	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	25.91	63.84	2.62	0.87	0.33	0.44	0.11
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	24.71	67.91	2.36	1.93	0.43	0.21	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	23.25	66.52	2.58	1.08	0.22	0.86	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	26.78	54.92	2.86	0.50	0.37	0.37	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	25.39	56.61	2.92	0.34	0.69	1.54	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	23.71	50.62	2.88	0.96	0.32	1.60	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	75.55	80.03	2.80	1.12	2.24	0.00	1.12
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	71.84	86.99	8.66	0.87	0.87	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	26.44	63.45	7.93	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	33.86	22.93	2.12	0.71	0.71	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	36.33	42.86	4.36	1.45	0.00	0.00	0.73
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	18.01	20.11	1.05	0.00	0.00	0.17	0.00
Hepatocyte, donor1	11523-119I2	37.53	24.21	3.63	0.00	0.00	0.00	1.21
Hepatocyte, donor2	11603-120I1	50.63	32.32	3.23	0.00	1.08	0.00	1.08
Hepatocyte, donor3	11684-122I1	58.29	28.22	5.52	1.23	0.00	0.00	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	116.83	120.75	13.71	1.31	0.65	3.92	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	35.13	18.88	7.52	0.17	0.70	0.17	0.52
Iris Pigment Epithelial Cells, donor1	11530-119I9	26.89	27.44	2.20	1.10	0.14	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	168.75	1060.24	9.55	9.55	0.00	6.37	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	93.45	714.26	13.35	0.00	0.00	6.68	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	54.17	1435.41	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	152.28	744.79	9.69	2.77	0.00	1.38	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	92.60	603.14	12.51	10.01	2.50	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	94.95	652.75	11.87	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	156.34	945.71	15.38	5.13	2.56	5.13	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	127.98	649.05	18.28	0.00	0.00	9.14	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	129.95	961.60	14.62	1.62	3.25	3.25	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	106.71	631.91	10.00	3.33	1.67	3.33	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	79.87	486.50	29.04	0.00	3.63	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	174.70	1105.10	17.21	5.29	2.65	9.26	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	116.41	624.17	11.09	3.33	0.00	4.43	1.11
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	178.10	707.17	36.67	5.24	5.24	5.24	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	109.60	631.75	13.23	2.52	1.89	5.04	0.63
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	134.56	637.21	24.75	1.55	3.09	1.55	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	43.90	512.22	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	140.19	913.50	18.74	2.58	0.65	5.81	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	169.04	1007.81	20.93	3.22	0.00	3.22	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	191.17	848.32	11.95	0.00	11.95	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	152.38	968.07	22.00	6.52	0.00	3.26	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	149.45	357.68	25.61	3.36	2.52	2.52	0.84
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	158.10	589.27	0.00	0.00	0.00	14.37	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	116.53	856.73	18.48	4.02	3.21	2.41	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	109.87	505.96	18.47	0.92	0.92	3.69	0.92
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	180.97	648.47	15.08	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	72.22	423.89	8.97	1.42	0.94	2.83	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	116.09	516.07	15.42	3.63	0.00	2.72	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	191.65	574.96	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	95.77	822.16	18.29	0.00	2.15	1.08	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	139.75	776.25	17.79	3.81	0.00	6.35	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	115.01	755.80	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	140.93	875.53	22.32	3.19	1.91	5.74	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	91.13	887.64	14.58	3.65	0.00	7.29	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	110.63	821.83	31.61	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	140.67	784.76	22.14	3.57	0.71	0.71	0.71
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	139.37	962.31	29.86	3.32	3.32	3.32	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	145.94	833.94	20.85	0.00	0.00	0.00	20.85
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	83.03	402.18	10.49	1.23	1.54	2.47	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	198.43	842.89	14.05	1.76	0.00	10.54	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	150.87	748.06	6.29	0.00	3.14	3.14	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	164.11	783.70	15.30	0.00	0.70	1.39	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	188.11	975.97	26.56	4.43	4.43	2.21	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	116.71	829.96	12.97	6.48	0.00	3.24	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	169.15	787.35	15.69	3.49	2.62	4.36	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	168.73	1039.40	24.75	4.50	0.00	6.75	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	125.44	1115.06	20.91	3.48	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	132.28	843.82	14.93	6.40	2.13	3.20	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	126.08	1072.33	8.31	2.77	4.16	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	173.83	1370.66	11.40	0.00	0.00	8.55	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	141.75	1112.79	12.89	2.76	0.92	3.68	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	121.01	762.38	12.10	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	93.13	1161.02	12.42	0.00	0.00	12.42	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	149.09	841.67	5.29	6.34	0.00	5.29	0.00
Keratinocyte - epidermal, donor1	11272-116H3	32.97	19.99	2.53	0.57	1.06	0.16	0.49
Keratinocyte - epidermal, donor2	11349-117G8	45.68	20.50	3.51	0.00	0.59	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	42.88	26.69	1.23	0.66	0.09	0.09	0.00
Keratinocyte - oral, donor1	11251-116E9	61.41	13.96	6.81	0.45	0.45	0.11	0.11
Keratocytes, donor1	11527-119I6	102.12	50.54	14.44	1.72	1.38	0.69	0.34
Keratocytes, donor2	11607-120I5	46.87	32.81	4.69	0.00	0.00	0.00	0.00
Keratocytes, donor3	11688-122I5	70.74	28.26	2.37	0.40	0.20	0.40	0.40
Krukenberg tumor cell line:HSKTC	10687-109F3	76.93	52.75	0.00	0.00	0.00	2.20	0.00
Lens Epithelial Cells, donor1	11529-119I8	30.20	36.68	1.08	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	30.22	33.56	4.50	1.04	0.35	0.23	0.00
Lens Epithelial Cells, donor3	11690-122I7	35.02	25.03	2.72	0.61	0.91	0.10	0.10
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	39.72	18.97	6.40	0.95	1.19	0.12	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	29.30	12.28	5.58	1.67	0.84	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	34.00	22.35	7.08	0.79	0.79	0.00	0.31
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	35.49	26.89	4.84	1.08	0.54	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	43.81	27.42	5.67	0.00	0.95	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	33.96	22.96	5.71	0.65	0.65	0.00	0.22
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	27.91	12.31	5.34	0.82	0.82	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	32.87	20.98	6.57	0.51	0.51	0.00	0.25
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	31.39	20.97	7.32	0.42	2.25	0.14	0.14
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	30.46	19.78	6.72	0.40	1.58	0.40	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	30.05	16.48	5.62	0.78	0.97	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	25.37	21.11	6.67	0.37	2.22	0.00	0.37
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	27.53	15.68	5.57	0.70	1.05	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	30.29	18.84	7.16	0.24	0.72	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	30.77	22.94	6.32	1.10	1.51	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	31.10	17.25	6.47	0.62	1.85	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	25.25	16.83	5.61	0.62	0.31	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	33.85	25.98	9.52	0.55	1.46	0.00	0.18
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	29.95	14.48	5.27	0.66	1.65	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	30.75	17.57	6.15	0.59	0.29	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	27.88	28.63	7.22	1.49	1.49	0.00	0.75
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	27.16	14.06	4.36	0.00	0.97	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	32.32	16.70	3.77	0.54	1.35	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	28.76	24.07	7.27	0.61	2.57	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	24.88	13.48	9.85	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	30.15	17.80	4.19	2.09	1.05	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	33.08	18.65	6.92	0.75	1.65	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	22.01	26.14	5.50	0.69	2.75	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	25.40	20.88	5.08	0.94	0.75	0.38	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	28.95	20.68	8.16	0.21	0.95	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	25.20	21.32	4.85	0.48	0.97	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	20.84	23.16	3.64	0.33	0.99	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	27.26	22.55	6.94	0.50	0.99	0.12	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	28.51	20.36	5.18	1.11	0.37	0.37	0.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	24.21	14.33	4.94	0.25	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	27.50	19.94	7.84	0.41	1.10	0.00	0.14
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	28.30	16.08	7.08	0.96	0.64	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	24.96	22.22	6.70	0.61	2.74	0.00	0.30
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	26.45	17.36	5.88	0.84	1.54	0.00	0.28
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	22.40	16.00	6.04	1.07	0.71	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	22.78	16.97	4.85	0.48	1.94	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	27.08	25.21	7.78	0.47	1.40	0.00	0.16
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	26.14	13.97	4.66	0.72	1.79	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	30.05	29.73	5.23	0.98	0.65	0.00	0.33
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	30.84	26.84	6.83	1.18	1.18	0.00	0.24
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	40.96	20.91	7.92	1.24	1.49	0.37	0.25
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	32.02	20.49	3.07	0.77	1.54	0.00	0.26
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	29.24	25.06	5.97	1.19	0.90	0.00	0.30
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	52.12	72.51	18.13	0.00	0.00	4.53	2.27
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	89.75	114.30	20.71	0.77	0.00	0.77	0.77
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	63.83	99.46	17.07	0.74	0.00	2.97	0.74
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	64.74	125.25	17.35	1.69	0.85	2.54	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	68.93	92.84	10.55	1.41	1.41	1.41	0.70
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	50.43	110.21	15.88	0.00	1.87	0.93	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	53.07	94.29	12.37	1.03	0.52	3.09	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	77.31	111.81	10.71	1.19	1.19	1.19	2.38
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	54.51	51.57	15.83	2.26	2.26	0.90	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	53.22	77.94	11.05	1.16	2.33	2.33	0.29
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	58.07	80.13	7.20	0.90	2.25	1.80	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	74.92	69.37	22.22	2.03	2.85	1.49	0.54
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	82.16	138.65	18.49	3.59	2.57	3.08	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	66.69	75.51	12.35	1.06	1.06	1.06	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	32.65	59.97	10.66	0.67	0.00	0.67	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	91.18	215.98	19.87	2.04	1.02	2.55	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	61.37	76.31	9.34	2.13	1.60	1.60	1.33
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	62.35	97.12	14.36	1.70	1.51	2.46	1.13
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	80.38	202.48	19.02	2.45	3.07	1.84	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	101.11	146.78	17.94	2.45	4.08	2.45	1.63
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	59.77	77.88	12.08	1.87	2.29	1.46	1.67
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	65.30	99.49	12.89	1.68	0.84	1.96	1.12
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	88.61	159.70	14.42	1.03	2.06	0.00	1.03
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	67.06	91.16	10.45	1.74	1.74	2.03	1.74
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	56.50	84.90	12.85	2.39	1.49	1.49	0.30
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	55.33	78.01	13.28	1.66	0.55	0.55	2.77
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	101.10	165.43	27.57	3.89	1.77	1.77	2.12
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	71.54	137.92	19.18	1.11	0.74	1.48	0.74
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	69.08	134.70	17.27	1.15	2.30	3.45	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	76.37	138.15	20.72	4.22	2.30	1.92	1.15
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	67.94	165.88	13.02	1.70	2.83	2.26	2.26
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	70.56	137.84	13.95	1.64	1.64	2.46	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	80.44	163.58	16.27	3.16	1.36	1.36	1.36
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	56.73	147.94	17.24	2.87	2.15	4.31	3.59
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	72.45	129.96	17.18	2.24	3.73	1.49	0.75
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	86.95	108.13	20.07	1.86	1.86	3.72	1.11
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	65.04	101.23	13.35	2.15	1.29	1.29	1.72
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	71.93	110.46	11.99	5.99	1.71	2.57	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	77.30	121.94	16.33	3.33	3.00	2.00	0.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	71.19	154.45	15.69	3.62	1.21	3.62	3.62
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	78.21	137.93	11.38	3.55	1.42	2.84	1.42
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	84.90	113.77	12.72	0.34	1.03	1.72	1.37
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	68.70	154.58	15.03	1.61	2.68	1.61	0.54
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	79.46	147.47	11.45	4.71	1.35	0.67	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	95.57	132.61	16.30	1.48	0.74	2.22	1.11
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	45.35	59.31	11.63	1.16	1.16	2.33	1.16
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	70.87	129.04	13.75	3.17	0.00	1.06	1.06
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	92.03	131.25	17.61	1.60	0.40	1.60	0.80
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	72.69	163.55	20.35	0.73	1.45	1.45	2.18
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	98.88	175.53	22.23	0.77	1.53	7.67	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	75.96	147.00	16.77	2.96	1.48	1.97	0.99
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	49.87	190.07	16.00	0.94	3.76	6.59	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	97.55	159.39	14.08	2.01	0.00	2.01	2.01
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	91.03	152.76	16.67	1.80	1.35	4.51	1.35
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	67.12	180.72	22.37	1.72	0.00	3.44	3.44
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	71.70	183.48	18.26	2.23	0.89	1.78	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	95.80	178.70	20.33	1.56	2.35	1.96	1.17
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	69.27	169.55	21.77	3.30	3.30	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	80.95	177.47	18.68	2.59	0.52	1.04	0.52
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	98.89	156.21	18.38	3.94	0.88	2.63	2.63
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	76.60	180.59	20.69	2.24	0.56	2.24	1.12
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	82.15	167.82	22.08	1.77	2.65	2.21	1.32
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	84.09	176.27	19.29	1.93	1.54	1.93	2.31
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	67.35	176.21	22.28	2.03	1.52	1.01	0.51
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	90.36	173.50	16.34	3.84	1.92	1.92	2.40
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	79.11	143.91	19.88	1.59	0.80	1.59	0.80
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	76.56	202.95	15.80	4.25	6.08	2.43	1.22
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	67.79	183.30	13.83	2.08	2.77	1.38	1.38
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	90.06	170.62	20.90	6.08	0.38	2.66	1.52
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	84.18	203.47	30.47	4.13	3.61	1.55	0.52
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	85.26	187.44	24.79	4.23	5.44	2.42	3.02
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	101.09	147.04	19.65	4.12	1.58	1.58	2.22
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	103.42	254.82	29.32	4.26	3.20	3.73	1.07
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	91.95	191.94	27.01	3.45	2.87	1.15	1.72
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	95.65	192.84	27.77	3.09	1.54	3.09	1.54
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	80.64	203.01	29.00	1.41	6.37	2.12	2.83
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	91.37	203.16	25.54	5.67	2.84	0.57	2.27
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	97.77	163.91	27.46	2.08	2.08	2.50	1.25
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	77.52	194.19	37.59	4.70	1.57	1.57	0.78
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	57.62	151.15	24.64	3.76	3.34	0.42	1.25
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	85.49	165.41	22.30	3.72	0.46	1.39	1.39
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	79.62	179.97	14.05	2.01	2.01	0.67	1.34
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	75.92	158.25	20.85	4.28	1.60	2.67	1.60
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	99.81	144.67	20.61	3.23	2.02	2.42	2.02
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	89.94	179.88	27.53	1.84	2.75	4.59	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	70.24	200.05	16.00	4.45	4.45	1.78	2.67
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	107.71	184.07	25.64	3.42	4.56	1.71	2.28
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	71.32	220.87	20.71	4.60	2.30	2.30	2.30
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	84.81	192.06	19.70	4.38	1.09	2.74	1.64
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	110.03	163.48	18.71	3.12	0.00	3.12	1.34
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	85.79	85.79	20.54	3.64	2.60	1.56	1.82
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	96.81	196.94	16.58	3.32	1.99	1.33	1.33
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	106.01	266.06	20.79	2.08	2.08	2.08	4.16
Macrophage - monocyte derived, donor1	11232-116C8	39.20	6.84	5.47	0.23	1.14	0.00	0.00
Macrophage - monocyte derived, donor2	11313-117C8	23.67	13.58	6.42	1.10	0.55	0.00	0.37
Macrophage - monocyte derived, donor3	11389-118C3	47.06	10.36	7.86	1.31	0.26	0.00	0.00
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	14.34	9.03	1.06	0.00	0.53	0.00	0.00
Mallassez-derived cells, donor2	11929-125I3	24.88	12.83	2.22	0.32	0.32	0.00	0.00
Mallassez-derived cells, donor3	11930-125I4	24.60	24.18	2.50	0.83	0.69	0.00	0.00
Mammary Epithelial Cell, donor1	11273-116H4	52.51	20.13	6.88	0.80	0.30	0.50	0.10
Mammary Epithelial Cell, donor2	11350-117G9	39.67	19.40	10.42	0.29	0.58	0.29	0.58
Mammary Epithelial Cell, donor3	11422-118F9	59.36	37.41	3.99	1.50	0.25	0.25	0.00
Mast cell - stimulated, donor1	11487-119E2	44.74	100.33	54.91	4.07	4.07	1.36	4.07
Mast cell, donor1	11563-120D6	77.10	36.88	28.77	6.06	3.03	0.32	4.11
Mast cell, donor2	11565-120D8	110.85	30.61	31.20	2.38	2.38	0.30	3.57
Mast cell, donor3	11566-120D9	121.12	20.04	43.00	2.48	4.95	0.23	4.73
Mast cell, donor4	11567-120E1	118.25	23.76	30.32	3.01	3.55	0.35	4.43
Mast cell, expanded and stimulated, donor5	11940-126A5	85.94	76.41	23.40	4.44	2.00	0.33	1.77
Mast cell, expanded and stimulated, donor8	11942-126A7	54.28	84.05	93.97	12.84	10.51	0.00	3.50
Mast cell, expanded, donor5	11939-126A4	65.51	35.33	20.65	1.95	1.72	0.00	4.82
Mast cell, expanded, donor8	11941-126A6	120.00	33.64	31.63	5.36	5.36	0.00	7.03
Melanocyte - dark, donor1	11502-119F8	30.65	9.45	4.08	0.30	1.19	0.00	0.00
Melanocyte - dark, donor2	11582-120F7	20.07	25.26	1.04	0.69	0.69	0.00	0.00
Melanocyte - dark, donor3	11663-122F7	41.15	32.74	2.68	0.58	0.22	0.36	0.14
Melanocyte - light, donor1	11274-116H5	51.25	53.13	4.94	1.88	0.47	0.00	3.53
Melanocyte - light, donor2	11351-117H1	53.91	85.31	7.51	2.05	1.36	0.00	4.09
Melanocyte - light, donor3	11423-118G1	44.23	52.90	1.73	0.87	0.00	0.00	1.73
Melanocyte, donor1 (MC+1)	12641-134G4	34.88	62.89	2.92	0.62	0.42	0.00	0.62
Melanocyte, donor2 (MC+2)	12739-135I3	18.83	12.37	2.42	0.54	0.00	0.00	0.00
Melanocyte, donor3 (MC+3)	12837-137B2	34.55	46.87	2.14	0.27	0.00	0.54	0.80
Meningeal Cells, donor1	11493-119E8	58.80	68.98	18.61	6.08	0.99	0.37	0.12
Meningeal Cells, donor2	11573-120E7	51.94	140.85	10.12	3.96	1.32	0.00	0.00
Meningeal Cells, donor3	11654-122E7	37.82	42.14	13.69	3.99	0.82	0.16	0.00
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	39.64	31.94	2.00	0.00	0.00	0.29	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	22.14	12.68	2.92	0.60	0.81	0.10	0.00
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	52.57	72.28	2.63	0.00	1.31	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	47.09	85.03	7.85	1.31	0.00	1.31	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	28.70	34.45	2.15	0.00	0.72	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	21.81	22.02	1.27	0.42	0.00	0.00	0.42
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	27.14	55.79	1.01	0.50	0.00	0.00	0.50
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	45.05	47.25	6.15	1.32	0.66	0.44	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	64.29	91.32	5.11	4.38	1.46	0.73	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	56.47	96.78	7.98	1.43	0.61	0.41	0.20
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	26.87	14.27	6.09	0.00	0.14	0.00	0.14
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	23.42	31.97	1.86	0.37	0.37	0.37	0.37
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	36.71	14.34	3.82	0.13	0.26	0.13	0.00
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	24.33	21.37	4.45	0.00	0.89	0.00	0.30
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	42.04	58.39	0.00	0.00	2.34	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	52.51	55.07	4.48	0.00	1.28	0.64	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	25.87	16.30	2.48	0.00	1.06	0.35	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	29.71	8.44	1.56	0.31	0.00	0.63	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	28.30	33.38	5.81	0.00	0.00	0.73	0.00
Mesothelial Cells, donor1	11247-116E5	21.21	12.46	2.12	0.00	0.27	0.00	0.00
Mesothelial Cells, donor2	12156-128G5	15.51	13.51	0.50	0.50	0.00	0.00	0.00
Mesothelial Cells, donor3	11402-118D7	24.28	15.39	1.66	0.51	0.00	0.14	0.14
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	9.45	20.25	6.75	1.35	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	44.82	24.87	3.94	0.74	0.00	0.00	0.25
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	30.92	28.56	6.18	1.18	0.00	0.00	0.29
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	31.11	6.91	6.91	0.00	3.46	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	30.37	12.71	4.03	0.93	0.00	0.00	0.93
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	21.99	23.03	5.39	1.45	0.62	0.21	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	13.90	6.95	2.32	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	36.29	18.77	2.75	1.25	0.50	0.00	0.25
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	35.38	31.65	6.05	2.33	1.40	0.00	0.47
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	27.64	19.51	3.66	0.41	0.81	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	23.36	21.78	6.34	1.58	0.40	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	34.21	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	23.01	23.01	4.42	0.88	0.88	0.88	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	19.76	31.15	4.94	0.76	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	19.74	9.21	1.32	1.32	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	19.74	16.98	4.03	1.06	0.42	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	18.42	34.07	3.68	0.00	0.92	0.92	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	215.66	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	22.65	23.55	5.07	0.60	0.89	0.00	0.30
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	43.59	35.21	5.03	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	67.90	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	19.57	16.56	2.26	0.75	0.75	0.25	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	22.10	25.91	3.80	0.95	0.00	0.00	0.24
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	6.63	7.19	2.76	0.00	1.66	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	15.43	18.65	1.61	1.15	0.92	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	19.56	22.09	5.89	1.89	0.63	0.00	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	9.99	14.27	3.47	1.02	0.20	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	17.81	14.37	3.22	1.50	0.43	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	24.90	25.34	2.45	1.78	0.67	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	20.64	10.32	10.32	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	15.99	9.86	3.29	0.66	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	19.77	23.32	3.04	1.01	0.51	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	8.28	3.31	1.66	1.66	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	16.04	13.59	4.62	0.54	0.00	0.54	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	17.94	26.47	6.47	0.29	0.59	0.29	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	11.99	7.63	2.18	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	13.46	15.86	3.84	0.96	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	14.81	18.41	2.00	2.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	21.94	13.71	2.74	1.37	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	18.02	9.51	2.00	0.50	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	80.84	26.95	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	24.46	18.35	2.04	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	16.64	7.44	2.19	0.88	0.44	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	33.11	8.83	3.31	0.00	3.31	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	30.74	7.68	2.56	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	21.07	9.17	0.99	0.74	0.74	0.25	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	20.18	9.05	0.70	1.39	0.70	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	24.31	6.63	2.21	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	20.85	7.18	3.76	1.37	1.03	0.00	0.34
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	39.39	5.25	4.38	0.88	0.44	0.44	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	29.47	8.52	3.91	0.00	0.36	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	22.44	5.61	1.40	0.28	0.28	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	28.26	2.49	4.99	1.66	0.83	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	30.89	9.32	2.33	0.00	0.00	0.58	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	28.66	3.32	5.73	0.90	0.90	0.00	0.30
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	27.55	2.09	10.02	2.09	0.42	0.00	0.42
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	21.66	7.22	7.22	7.22	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	40.64	12.01	4.62	0.00	0.00	0.00	0.92
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	27.89	5.69	8.54	0.57	1.14	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	22.25	5.67	4.42	0.69	0.28	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	25.66	4.66	2.85	1.30	0.78	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	37.75	5.58	7.29	0.86	1.29	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	28.58	4.45	1.91	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	34.96	5.87	4.80	1.07	0.27	0.27	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	40.11	5.99	11.08	1.50	0.60	0.00	0.60
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	22.46	3.39	2.26	0.99	0.28	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	21.98	2.87	6.37	1.27	2.23	0.00	0.32
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	42.68	5.09	10.84	0.44	1.33	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	24.27	7.20	3.41	0.38	1.52	0.00	0.38
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	25.57	6.82	6.53	0.57	0.57	0.28	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	27.78	5.16	5.90	1.47	0.98	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	36.49	3.26	1.30	0.00	0.65	0.65	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	42.05	7.35	6.47	0.59	0.29	0.00	0.29
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	36.62	5.77	6.92	3.17	0.58	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	20.20	2.47	4.53	0.00	0.82	0.00	0.41
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	38.41	4.76	5.06	0.60	0.89	0.30	0.60
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	15.07	64.04	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	14.26	30.30	0.00	1.78	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	36.14	40.09	4.60	0.33	0.00	0.00	0.33
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	17.88	36.82	2.10	1.05	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	23.92	37.56	4.15	0.00	0.20	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	33.53	22.35	4.66	0.93	0.93	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	23.66	21.03	3.00	0.00	0.38	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	18.91	26.10	2.93	0.27	0.27	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	21.04	26.35	4.18	0.11	0.23	0.11	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	27.26	36.10	1.47	0.74	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	30.05	36.28	2.93	0.37	0.00	0.00	0.37
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	23.33	20.22	3.11	1.56	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	19.24	47.03	2.67	2.67	0.53	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	30.91	61.82	15.46	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	24.24	49.49	2.02	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	22.77	35.00	2.53	2.11	0.42	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	13.62	81.72	2.72	1.36	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	1.27	27.34	0.64	0.64	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	6.48	21.87	0.81	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	10.57	78.54	1.51	1.51	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	45.68	68.52	22.84	11.42	0.00	5.71	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	19.57	26.10	9.79	0.00	0.00	3.26	3.26
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	19.01	9.50	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	50.20	12.55	25.10	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	25.64	22.84	3.23	0.65	0.65	0.22	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	44.94	28.74	1.57	0.00	0.00	0.00	1.05
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	69.42	63.41	0.00	1.33	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	131.05	33.81	0.42	0.00	0.83	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	194.90	216.19	1.14	1.33	0.19	0.76	0.00
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	153.20	173.95	4.79	0.00	0.00	6.38	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	66.63	18.36	1.36	1.36	0.00	0.68	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	170.90	45.94	3.68	0.00	0.00	1.84	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	66.13	28.88	1.67	1.26	0.42	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	100.65	43.70	1.63	1.39	0.70	0.70	0.23
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	98.90	53.50	1.62	0.54	0.54	0.00	0.27
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	63.07	57.60	3.78	1.26	0.00	0.42	0.00
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	111.35	11.13	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	21.84	19.85	1.99	0.50	0.00	0.00	0.50
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	69.83	59.01	2.44	0.27	0.27	0.00	0.54
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	55.99	28.34	1.59	0.45	0.23	0.23	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	113.17	64.18	0.98	0.49	0.00	0.00	0.16
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	50.48	46.29	1.82	0.91	0.36	0.55	0.55
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	53.57	24.93	1.06	1.06	0.00	0.00	0.53
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	36.62	21.01	2.40	0.60	0.00	0.60	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	116.50	137.51	3.61	0.98	0.00	0.33	0.33
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	87.49	30.41	1.79	0.81	0.49	0.00	0.16
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	71.61	59.97	2.12	1.06	0.18	0.18	0.18
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	59.77	21.80	1.41	0.70	0.00	0.00	0.70
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	70.80	26.66	1.84	0.00	0.46	0.46	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	58.81	42.74	1.61	0.64	0.00	0.00	0.64
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	127.61	123.13	1.03	0.69	0.00	0.69	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	351.45	247.79	0.00	5.06	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	78.42	57.92	2.90	0.22	0.22	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	66.05	22.86	1.69	1.69	0.00	0.00	0.42
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	89.24	37.26	1.19	1.19	0.00	0.24	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	45.50	35.63	1.72	1.29	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	27.08	54.17	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	63.31	52.32	0.67	0.33	0.00	0.33	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	58.16	56.81	1.80	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	40.87	34.12	0.79	0.40	0.40	0.79	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	61.29	26.93	0.93	0.93	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	46.16	47.30	0.76	1.89	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	49.86	37.15	1.63	0.00	0.00	0.00	0.33
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	81.49	60.57	0.44	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	66.94	47.04	1.81	0.45	0.45	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	44.10	29.98	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	41.89	27.26	0.66	0.66	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	36.21	65.48	0.99	0.50	0.00	0.50	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	62.40	34.84	1.15	0.00	0.00	0.38	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	65.03	49.60	1.81	0.00	0.30	0.30	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	42.88	53.71	1.11	0.44	0.00	0.22	0.44
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	47.44	34.56	2.71	1.36	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	76.64	51.10	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	35.36	42.07	0.00	0.61	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	71.13	32.73	1.57	1.26	0.00	0.00	0.31
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	119.55	97.15	1.21	0.61	0.30	0.30	0.30
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	41.93	41.14	3.96	0.00	0.00	0.00	0.79
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	197.25	137.17	1.13	2.27	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	96.10	45.52	0.00	0.00	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	21.24	8.94	2.86	0.50	0.00	0.25	0.12
Myoblast, donor2	11322-117D8	38.36	29.92	2.49	0.77	0.19	0.00	0.00
Myoblast, donor3	11398-118D3	30.27	23.37	2.86	0.67	0.34	0.50	0.17
NK T cell leukemia cell line:KHYG-1	10777-110G3	109.89	27.29	8.61	1.75	0.44	0.88	0.15
Natural Killer Cells, donor1	11230-116C6	112.55	34.44	20.60	4.00	2.46	0.00	1.85
Natural Killer Cells, donor2	11311-117C6	121.23	31.66	17.19	3.02	3.62	0.00	0.00
Natural Killer Cells, donor3	11387-118C1	131.78	34.42	18.96	3.31	3.31	0.37	2.39
Neural stem cells, donor1	11275-116H6	60.61	102.71	22.50	2.90	3.27	1.09	1.45
Neural stem cells, donor2	11352-117H2	59.69	88.58	15.41	1.93	0.00	1.93	1.93
Neurons, donor1	11494-119E9	29.59	114.93	3.41	1.14	0.00	1.14	0.00
Neurons, donor2	11574-120E8	34.13	51.30	2.42	0.22	0.44	0.00	0.22
Neurons, donor3	11655-122E8	37.00	189.10	3.29	0.82	0.00	4.11	0.00
Neutrophils, donor1	11233-116C9	54.75	22.27	13.92	0.00	2.78	0.93	0.93
Neutrophils, donor2	11314-117C9	107.26	23.19	23.19	0.00	0.00	0.00	2.90
Neutrophils, donor3	11390-118C4	106.90	25.04	30.54	3.67	3.05	0.00	1.22
Nucleus Pulposus Cell, donor1	11252-116F1	40.01	15.44	3.09	0.12	0.12	0.12	0.00
Nucleus Pulposus Cell, donor2	11409-118E5	25.07	20.51	1.30	0.65	0.00	0.00	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	33.29	23.67	2.01	0.00	0.20	0.40	0.00
Olfactory epithelial cells, donor1	11933-125I7	37.03	27.53	0.83	0.14	0.00	0.00	0.14
Olfactory epithelial cells, donor2	11934-125I8	38.94	50.66	1.45	0.29	0.14	0.00	0.00
Olfactory epithelial cells, donor3	11935-125I9	36.89	35.30	2.16	0.34	0.00	0.11	0.00
Olfactory epithelial cells, donor4	11936-126A1	58.83	32.14	2.43	0.10	0.29	0.00	0.10
Oligodendrocyte - precursors, donor1	11496-119F2	33.10	16.25	6.62	0.00	0.00	0.00	0.00
Osteoblast - differentiated, donor1	11276-116H7	45.09	14.68	11.91	0.64	2.55	0.43	1.49
Osteoblast - differentiated, donor2	11353-117H3	22.86	13.72	3.43	0.00	0.00	2.29	5.72
Osteoblast - differentiated, donor3	11425-118G3	37.86	22.97	2.48	0.62	0.00	0.00	0.62
Osteoblast, donor1	11277-116H8	52.18	44.76	5.08	0.59	0.78	0.20	0.39
Osteoblast, donor2	11354-117H4	35.12	33.71	2.81	1.40	1.40	0.00	0.00
Osteoblast, donor3	11426-118G4	50.83	36.43	3.91	0.89	1.07	0.36	0.71
Pancreatic stromal cells, donor1	11249-116E7	33.95	23.59	3.45	0.76	0.42	0.51	0.25
Pericytes, donor1	11491-119E6	43.84	35.27	6.34	2.45	0.00	0.33	0.45
Pericytes, donor2	11571-120E5	48.67	36.67	2.94	1.13	0.68	0.00	0.00
Pericytes, donor3	11652-122E5	43.74	51.27	3.26	0.61	1.22	0.41	0.00
Perineurial Cells, donor1	11499-119F5	32.55	22.38	6.67	1.36	0.45	0.11	0.00
Perineurial Cells, donor2	11579-120F4	31.38	18.40	3.50	0.28	0.55	0.18	0.00
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	107.73	43.67	18.81	1.91	3.51	0.00	0.64
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	92.07	38.69	14.69	1.22	1.22	0.24	0.73
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	122.56	31.45	13.72	1.16	0.65	0.13	1.04
Placental Epithelial Cells, donor1	11278-116H9	34.92	43.29	6.22	1.20	0.96	0.00	0.24
Placental Epithelial Cells, donor2	11355-117H5	28.83	53.23	6.65	0.00	0.00	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	34.75	47.51	3.73	0.39	0.98	0.39	0.20
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	20.25	16.46	0.95	0.00	0.32	0.00	0.00
Preadipocyte - breast, donor1	11467-119B9	15.57	15.57	2.63	0.56	0.19	0.00	0.38
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	42.16	13.84	5.09	0.91	0.78	0.26	0.00
Preadipocyte - breast, donor2	11328-117E5	24.54	17.79	1.58	0.23	0.23	0.23	0.00
Preadipocyte - omental, donor1	11468-119C1	23.98	20.46	2.88	0.64	0.32	0.21	0.21
Preadipocyte - omental, donor2	11329-117E6	26.62	19.64	2.18	0.87	0.87	0.00	0.00
Preadipocyte - omental, donor3	11403-118D8	38.25	34.95	2.01	0.86	0.43	0.00	0.14
Preadipocyte - perirenal, donor1	11469-119C2	19.69	34.45	1.97	0.00	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	68.18	51.60	7.99	3.07	0.92	0.00	1.23
Preadipocyte - subcutaneous, donor2	11356-117H6	46.22	48.34	5.31	1.59	0.53	0.35	0.18
Preadipocyte - subcutaneous, donor3	11428-118G6	28.27	29.97	1.87	1.53	1.36	0.00	0.34
Preadipocyte - visceral, donor1	11280-116I2	36.61	22.54	4.10	1.40	0.56	0.28	0.09
Preadipocyte - visceral, donor2	11357-117H7	37.73	26.69	3.22	0.00	0.92	0.00	0.46
Preadipocyte - visceral, donor3	11429-118G7	33.65	26.85	2.61	0.73	0.21	0.10	0.31
Prostate Epithelial Cells (polarized), donor1	11253-116F2	27.00	24.74	7.39	1.81	0.75	0.45	1.36
Prostate Epithelial Cells, donor2	11331-117E8	29.11	11.37	1.76	1.08	0.81	0.54	0.41
Prostate Epithelial Cells, donor3	11404-118D9	47.95	22.35	1.47	0.49	0.24	0.67	0.43
Prostate Stromal Cells, donor1	11254-116F3	29.61	14.24	3.08	0.91	0.46	0.23	0.23
Prostate Stromal Cells, donor2	11332-117E9	46.62	67.60	5.02	0.72	1.08	0.36	0.54
Prostate Stromal Cells, donor3	11405-118E1	32.43	21.27	2.09	0.42	0.10	0.21	0.83
Renal Cortical Epithelial Cells, donor1	11516-119H4	70.81	29.93	10.22	1.82	1.46	0.73	0.73
Renal Cortical Epithelial Cells, donor2	11596-120H3	30.64	20.03	2.77	0.49	0.42	0.14	0.00
Renal Epithelial Cells, donor1	11517-119H5	81.66	57.32	6.59	2.03	1.52	0.00	0.51
Renal Epithelial Cells, donor2	11597-120H4	59.04	80.38	7.82	0.00	0.00	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	31.55	24.45	4.55	0.32	0.42	0.11	0.21
Renal Glomerular Endothelial Cells, donor1	11514-119H2	77.62	92.60	6.81	0.00	1.36	0.68	0.68
Renal Glomerular Endothelial Cells, donor2	11594-120H1	60.64	70.35	4.58	0.94	1.08	0.13	0.40
Renal Glomerular Endothelial Cells, donor3	11675-122H1	60.83	62.83	5.33	1.78	0.44	0.22	0.00
Renal Glomerular Endothelial Cells, donor4	11783-124B1	55.23	125.10	5.32	1.33	0.00	0.00	0.67
Renal Mesangial Cells, donor1	11518-119H6	44.68	33.23	6.16	1.32	0.44	0.44	0.00
Renal Mesangial Cells, donor2	11598-120H5	44.52	26.96	5.02	0.00	0.63	0.00	0.63
Renal Mesangial Cells, donor3	11679-122H5	51.88	44.11	2.50	0.28	0.83	0.28	0.28
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	37.58	32.75	4.03	2.15	0.81	0.54	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	45.96	41.33	2.11	0.42	0.42	0.00	0.42
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	61.13	70.97	6.75	0.58	0.96	0.39	0.19
Retinal Pigment Epithelial Cells, donor0	11215-116A9	32.15	33.97	2.59	0.52	0.52	0.78	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	43.49	40.65	1.99	0.28	0.85	0.00	0.57
Retinal Pigment Epithelial Cells, donor2	11608-120I6	43.22	113.20	6.17	0.00	1.03	1.03	1.03
Retinal Pigment Epithelial Cells, donor3	11689-122I6	19.07	34.88	3.76	0.25	0.75	0.50	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	60.94	26.19	5.08	1.07	0.80	0.27	0.94
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	59.86	46.46	11.61	4.47	0.00	0.89	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	53.39	73.75	17.61	2.75	2.20	1.65	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	97.45	71.93	14.50	4.06	4.06	0.58	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	58.64	69.69	8.97	1.43	0.39	1.30	0.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	64.85	57.30	7.45	2.09	0.99	1.49	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	58.45	52.53	10.04	2.01	0.56	1.23	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	61.15	47.14	8.56	2.23	0.37	0.74	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	60.49	54.08	7.34	1.40	0.70	0.47	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	82.28	76.50	10.86	1.85	0.92	2.77	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	75.57	70.64	5.89	1.51	0.68	0.68	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	66.71	58.69	7.56	1.51	1.21	1.36	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	57.88	46.23	10.93	1.43	0.72	0.72	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	63.26	63.98	8.18	1.58	0.29	1.72	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	57.74	53.44	8.16	1.72	1.07	1.29	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	79.21	67.04	10.84	0.89	0.89	0.89	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	84.12	97.88	9.18	2.49	1.34	0.96	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	81.98	66.70	7.55	2.52	0.75	1.12	0.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	67.46	84.37	12.21	1.32	1.13	2.25	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	95.95	81.48	8.76	2.65	1.06	0.93	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	70.38	63.27	7.79	1.75	0.97	2.34	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	65.69	68.17	9.55	2.29	0.57	2.29	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	65.14	64.50	4.91	2.35	1.71	0.64	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	59.42	74.56	10.93	2.24	1.96	1.68	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	68.70	82.54	8.72	2.39	1.03	1.71	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	85.88	80.77	7.84	2.01	0.55	1.64	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	69.16	64.26	10.06	2.08	0.86	2.08	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	71.32	60.58	8.73	2.82	1.34	1.88	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	55.43	81.38	11.09	2.83	0.94	1.18	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	59.33	62.90	11.11	1.98	1.19	1.19	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	80.21	75.30	9.59	2.10	1.17	1.87	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	58.68	71.74	9.33	2.90	1.45	1.24	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	54.86	77.42	10.62	1.33	1.77	0.66	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	80.21	86.27	8.36	3.13	0.84	1.67	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	65.27	76.17	10.50	1.75	0.81	1.35	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	86.17	87.87	10.39	2.55	1.36	1.36	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	82.32	85.22	13.11	2.51	1.93	1.74	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	59.32	72.04	12.72	2.06	2.06	0.34	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	88.06	60.22	9.46	2.33	0.69	0.96	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	62.55	66.82	8.70	1.64	1.31	1.64	0.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	73.11	68.68	7.16	2.73	1.02	0.34	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	61.25	43.35	6.21	2.37	0.15	0.89	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	67.70	73.03	7.46	1.60	0.53	2.13	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	77.84	69.69	8.71	3.04	1.11	1.66	0.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	60.00	53.57	5.00	2.14	0.24	0.48	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	106.82	123.75	7.26	1.21	0.40	3.22	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	55.85	53.40	6.69	2.54	0.75	0.75	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	67.43	49.61	9.78	3.49	1.40	0.35	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	76.16	68.00	10.28	1.81	0.91	1.51	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	59.11	59.36	8.57	3.06	0.73	0.73	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	129.98	87.48	24.45	4.22	2.18	2.91	0.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	61.45	48.07	6.08	1.83	0.61	1.22	2.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	53.65	60.58	8.44	2.11	2.41	1.51	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	69.67	34.83	11.76	2.49	1.36	0.45	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	88.96	41.94	13.18	2.70	1.20	1.20	1.80
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	55.26	43.92	17.95	5.08	2.60	0.35	2.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	65.74	27.32	17.50	4.06	3.42	1.28	2.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	77.53	37.86	15.02	3.00	0.60	1.80	3.61
Schwann Cells, donor1	11498-119F4	71.66	110.77	9.03	0.94	0.38	0.00	0.00
Schwann Cells, donor2	11578-120F3	44.23	57.84	6.80	0.00	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	25.41	49.95	5.92	0.88	0.00	0.22	0.00
Sebocyte, donor1	11220-116B5	76.14	24.65	6.57	1.10	0.00	0.55	0.55
Sebocyte, donor2	11301-117B5	48.25	36.76	1.38	0.46	0.00	0.00	0.46
Sebocyte, donor3	11378-118B1	47.41	45.34	2.89	0.41	0.00	0.21	0.00
Sertoli Cells, donor1	11255-116F4	19.88	14.91	4.97	0.00	0.00	0.00	0.00
Sertoli Cells, donor2	11333-117F1	14.12	31.07	5.65	2.82	0.00	0.00	2.82
Skeletal Muscle Cells, donor1	11281-116I3	47.68	37.13	3.87	1.32	0.44	0.18	0.79
Skeletal Muscle Cells, donor2	11358-117H8	44.82	57.10	3.61	0.00	2.17	0.00	1.45
Skeletal Muscle Cells, donor3	11430-118G8	140.45	209.01	12.54	4.18	2.51	0.00	1.67
Skeletal Muscle Cells, donor4	11451-119A2	44.77	65.98	2.51	1.26	0.00	0.79	0.00
Skeletal Muscle Cells, donor5	11455-119A6	46.82	66.15	2.53	1.64	0.74	0.89	0.15
Skeletal Muscle Cells, donor6	11459-119B1	58.18	69.72	6.46	2.62	0.77	0.31	0.15
Skeletal Muscle Satellite Cells, donor1	11240-116D7	46.50	19.91	6.55	1.13	0.13	0.00	0.88
Skeletal Muscle Satellite Cells, donor2	11321-117D7	49.08	23.97	3.28	1.14	0.00	0.43	0.00
Skeletal Muscle Satellite Cells, donor3	11397-118D2	59.82	66.27	5.56	1.88	0.50	0.99	0.20
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	30.84	45.83	3.79	0.59	0.34	0.59	0.42
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	88.30	46.32	7.96	1.45	2.90	0.72	0.72
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	36.74	42.93	2.48	0.69	0.14	0.41	0.14
Skin - palm, donor1	10286-104F7	118.19	26.86	2.69	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	36.76	15.28	2.45	0.29	1.01	0.58	0.43
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	102.24	51.53	6.54	0.82	1.64	0.00	0.82
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	47.00	25.71	2.34	0.91	0.52	0.13	0.26
Small Airway Epithelial Cells, donor1	11256-116F5	22.10	10.01	2.78	1.11	0.42	0.00	0.97
Small Airway Epithelial Cells, donor2	11334-117F2	54.72	20.25	3.52	0.98	0.14	0.42	0.28
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	108.89	51.59	13.11	1.27	0.85	0.63	0.00
Small Airway Epithelial Cells, donor3	11406-118E2	78.17	22.93	3.67	0.82	0.60	0.60	0.75
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	24.69	4.01	2.16	0.62	0.93	0.00	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	38.24	16.45	5.11	0.22	0.67	0.22	0.44
Smooth Muscle Cells - Aortic, donor0	11210-116A4	48.79	16.46	3.53	2.35	1.76	0.59	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	63.20	20.33	3.31	0.44	1.10	0.00	0.44
Smooth Muscle Cells - Aortic, donor2	11360-117I1	29.53	17.72	3.54	0.39	1.58	0.00	0.39
Smooth Muscle Cells - Aortic, donor3	11432-118H1	50.22	12.36	3.86	0.77	0.77	0.00	2.32
Smooth Muscle Cells - Bladder, donor1	11519-119H7	28.02	43.03	4.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	45.38	18.10	3.86	0.67	0.93	0.40	1.06
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	23.05	21.94	2.88	0.66	0.00	0.22	0.22
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	8.07	15.11	0.38	0.13	0.38	0.26	0.00
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	21.81	12.37	3.91	1.95	0.33	0.33	0.33
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	25.10	15.36	1.77	0.30	0.59	0.00	0.30
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	29.90	17.37	1.57	0.00	0.28	0.00	0.14
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	41.32	17.57	4.39	0.81	0.49	0.16	0.16
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	52.67	22.53	2.13	0.00	0.00	0.30	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	66.68	20.21	6.06	2.27	1.01	0.25	1.52
Smooth Muscle Cells - Carotid, donor2	11362-117I3	226.47	30.60	6.12	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	42.92	41.96	3.81	0.95	0.00	0.48	0.95
Smooth Muscle Cells - Colonic, donor1	11239-116D6	21.24	14.30	2.06	0.29	0.74	0.00	0.00
Smooth Muscle Cells - Colonic, donor2	11320-117D6	33.36	29.70	1.08	0.22	0.22	0.86	0.43
Smooth Muscle Cells - Colonic, donor3	11396-118D1	42.19	37.05	3.15	0.63	0.42	0.21	0.00
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	49.65	19.03	7.42	1.55	1.39	0.46	1.08
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	29.10	22.64	3.23	0.00	1.08	0.00	1.08
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	34.97	18.23	1.79	0.00	0.30	0.30	0.30
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	45.41	34.14	6.49	2.05	0.34	0.68	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	36.83	10.37	2.98	0.24	0.39	0.00	0.16
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	33.31	16.81	5.74	2.21	1.31	0.10	1.91
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	31.17	9.56	2.96	0.23	0.46	0.23	0.23
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	40.46	25.36	4.83	0.00	1.81	0.00	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	54.57	51.40	3.44	1.85	1.06	0.53	0.00
Smooth Muscle Cells - Prostate, donor1	11257-116F6	29.30	22.77	3.73	0.53	0.27	0.00	0.80
Smooth Muscle Cells - Prostate, donor2	11335-117F3	32.06	22.79	2.00	1.13	0.75	0.13	0.50
Smooth Muscle Cells - Prostate, donor3	11465-119B7	18.52	10.91	3.55	0.51	0.25	0.00	0.76
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	40.56	13.72	3.92	0.90	0.15	0.00	0.30
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	28.51	16.50	1.50	0.00	0.00	0.75	2.25
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	606.05	130.51	7.75	1.29	1.29	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	64.64	35.35	4.19	0.93	0.93	0.00	0.47
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	28.78	26.76	1.51	0.50	1.01	0.50	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	50.46	17.24	2.82	1.25	0.31	0.00	0.63
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	22.12	10.32	4.13	1.18	0.00	0.00	0.29
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	35.32	17.58	5.50	0.92	0.83	0.08	0.00
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	24.76	17.75	0.47	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	38.28	22.02	4.17	0.58	0.29	0.00	0.29
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	60.42	27.79	4.33	0.76	1.02	0.25	0.25
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	47.57	33.66	1.88	0.56	0.38	0.56	0.19
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	37.59	21.94	6.71	0.28	0.42	0.14	0.00
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	24.97	8.97	2.60	0.34	0.59	0.25	0.00
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	61.90	20.00	2.86	1.43	0.95	0.95	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	36.94	15.41	3.91	1.22	0.24	0.00	0.24
Smooth Muscle Cells - Uterine, donor1	11258-116F7	29.61	20.11	1.99	1.55	0.22	0.00	0.22
Smooth Muscle Cells - Uterine, donor3	11466-119B8	36.28	25.45	3.51	0.88	0.59	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	36.15	34.01	1.94	1.17	0.00	0.00	0.39
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	27.77	25.92	2.12	0.79	0.79	0.26	0.00
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	18.60	30.50	1.12	0.00	0.00	0.37	0.74
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	25.87	20.84	1.44	0.36	0.00	0.36	0.36
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	34.35	20.16	0.28	0.00	0.00	0.57	0.85
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	37.02	30.33	3.54	1.18	0.79	1.58	0.39
Smooth muscle cells - airway, control, donor1	11966-126D4	18.03	18.54	0.76	0.51	0.00	0.00	1.27
Smooth muscle cells - airway, control, donor2	11967-126D5	34.34	23.56	1.20	0.40	0.80	0.00	0.40
Smooth muscle cells - airway, control, donor3	11968-126D6	33.86	15.88	2.09	0.00	0.42	0.00	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	25.21	27.50	1.38	0.46	0.00	0.00	0.00
Synoviocyte, donor1	11291-117A4	20.20	20.20	2.19	0.34	0.00	0.00	0.00
Synoviocyte, donor2	11368-117I9	25.48	8.55	1.68	0.17	0.34	0.00	0.67
Synoviocyte, donor3	11440-118H9	30.61	11.84	2.01	0.22	0.00	0.00	0.45
Trabecular Meshwork Cells, donor1	11532-120A2	76.83	62.18	10.01	1.07	0.36	0.00	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	81.26	81.26	0.00	1.98	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	81.97	79.42	3.47	0.93	0.46	0.46	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	48.39	13.40	4.66	0.50	0.79	0.07	0.50
Tracheal Epithelial Cells, donor2	11369-118A1	62.24	45.23	3.48	0.39	0.77	0.77	0.77
Tracheal Epithelial Cells, donor3	11441-118I1	58.41	38.37	4.01	1.72	1.72	2.29	1.15
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	63.73	24.73	4.92	1.35	1.60	0.12	0.86
Urethra, donor2	10319-105A4	147.47	37.77	14.39	0.00	0.00	0.00	0.00
Urothelial Cells, donor1	11520-119H8	40.91	15.41	2.66	0.80	0.27	0.00	0.80
Urothelial Cells, donor2	11600-120H7	36.05	22.03	3.61	0.00	0.00	0.40	0.40
Urothelial Cells, donor3	11681-122H7	59.59	27.50	2.29	0.46	0.23	0.00	0.69
Urothelial cells, donor0	11216-116B1	54.16	8.25	3.57	0.22	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	50.72	22.24	21.35	0.89	0.00	0.00	0.89
Whole blood (ribopure), donor090309, donation2	12180-129A2	68.62	18.58	7.15	0.00	4.29	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	67.08	19.85	12.32	0.00	1.37	0.00	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	54.41	16.53	13.43	0.00	1.03	0.00	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	51.13	15.11	15.11	0.58	0.58	0.00	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	59.35	15.62	11.45	2.08	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	40.38	16.52	12.85	0.00	0.92	0.00	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	65.73	14.61	12.78	0.00	0.00	0.00	0.00
Wilms' tumor cell line:G-401	10809-111A8	75.25	51.81	10.12	2.22	1.11	2.96	0.49
Wilms' tumor cell line:HFWT	10597-108E3	185.69	42.24	2.64	0.88	0.00	0.88	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	76.53	55.58	3.63	0.28	0.00	1.12	0.28
achilles tendon, donor2	10292-104G4	109.53	20.67	6.20	2.07	0.00	2.07	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	96.37	53.29	10.96	4.59	1.53	1.27	0.25
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	112.84	111.44	12.31	1.39	2.09	3.25	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	149.69	72.53	24.10	2.73	2.73	0.83	0.71
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	88.98	73.47	10.34	1.63	1.63	3.27	0.27
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	69.99	54.25	27.83	2.81	2.81	0.56	0.00
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	47.58	48.01	30.24	1.69	4.86	0.00	0.00
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	112.70	67.78	32.67	2.99	4.36	2.18	0.27
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	50.23	31.29	7.93	0.88	2.20	0.88	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	78.41	62.07	26.54	1.63	2.86	0.41	0.00
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	123.09	83.10	15.92	1.55	1.16	2.72	0.00
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	44.53	87.77	15.64	1.84	0.55	1.66	0.18
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	136.52	81.91	19.50	0.00	0.00	3.90	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	48.80	41.60	44.62	3.25	5.81	0.46	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	77.15	162.07	12.43	2.59	1.81	1.04	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	68.68	116.02	20.46	1.46	0.88	0.58	0.00
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	70.18	65.53	24.17	0.93	0.93	2.79	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	65.80	34.55	17.27	0.82	2.88	1.65	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	151.94	31.00	5.83	3.07	0.31	0.92	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	84.06	33.28	12.37	2.13	0.85	0.85	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	77.64	23.96	10.31	0.00	0.91	0.61	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	77.27	31.77	17.57	0.72	1.20	0.24	0.00
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	53.23	64.15	12.25	0.89	1.34	1.34	0.00
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	94.39	136.09	12.67	3.00	1.00	3.67	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	191.39	105.92	13.01	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	68.18	50.47	21.85	3.39	4.90	2.26	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	126.04	111.65	15.70	2.62	1.74	4.80	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	121.84	119.97	7.50	0.00	3.75	1.87	0.00
adenocarcinoma cell line:IM95m	10796-110I4	76.07	23.08	4.71	0.47	0.47	0.24	0.00
adipose tissue, adult, pool1	10010-101C1	34.13	20.01	4.19	0.78	1.24	0.00	1.24
adipose, donor1	10184-103D4	125.49	177.10	18.18	6.45	2.35	4.69	5.28
adipose, donor2	10185-103D5	122.87	88.81	26.36	2.03	0.81	1.62	2.43
adipose, donor3	10186-103D6	115.72	92.85	19.88	1.91	1.36	4.90	2.72
adipose, donor4	10187-103D7	260.89	75.41	10.40	1.73	1.73	7.80	1.73
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	123.89	65.65	4.73	0.95	1.74	0.95	0.16
adrenal gland, adult, pool1	10081-102A9	90.94	58.20	7.28	0.00	0.00	0.00	3.64
adult T-cell leukemia cell line:ATN-1	10421-106C7	98.32	89.38	10.81	0.93	0.80	1.20	0.27
alveolar cell carcinoma cell line:SW 1573	10708-109H6	96.47	93.61	5.72	1.07	1.07	3.57	0.00
amniotic membrane cells, donor1	12235-129G3	42.43	14.37	4.87	0.23	0.46	0.00	0.00
amniotic membrane cells, donor2	12236-129G4	46.32	19.27	7.44	0.34	0.34	0.00	0.00
amniotic membrane cells, donor3	12237-129G5	45.96	9.13	5.60	0.00	0.00	0.00	0.00
amygdala - adult, donor10196	10167-103B5	67.59	73.52	2.37	0.00	0.00	0.00	0.00
amygdala, adult, donor10252	10151-102I7	113.96	51.50	5.27	0.20	0.61	1.22	0.20
amygdala, newborn, donor10223	10360-105E9	78.76	63.59	6.46	1.29	0.00	0.00	0.32
anaplastic carcinoma cell line:8305C	10428-106D5	61.12	25.08	31.96	0.89	2.29	0.25	1.66
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	79.20	38.61	3.31	0.66	0.44	0.44	0.00
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	152.99	66.81	10.36	3.34	1.67	4.01	1.00
aorta, adult, pool1	10052-101G7	72.37	24.12	3.92	0.00	0.00	0.00	0.39
appendix, adult	10189-103D9	138.17	29.89	11.64	4.66	2.33	0.39	3.88
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	65.69	71.19	5.16	0.69	0.34	0.00	0.00
artery, adult	10190-103E1	43.48	20.38	6.79	1.36	1.36	0.00	1.36
astrocytoma cell line:TM-31	10425-106D2	45.63	27.67	5.22	0.43	0.58	0.29	0.58
b cell line:RPMI1788	10427-106D4	80.15	29.74	14.28	5.35	1.49	0.59	0.45
basal cell carcinoma cell line:TE 354.T	10702-109G9	31.07	6.38	2.50	0.00	0.00	0.28	0.00
bile duct carcinoma cell line:HuCCT1	10432-106D9	34.53	13.99	4.76	0.89	0.79	0.10	0.10
bile duct carcinoma cell line:TFK-1	10496-107C1	101.77	72.14	3.35	1.00	0.17	2.01	0.33
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	100.10	32.44	19.01	0.00	2.80	0.00	0.00
bladder, adult, pool1	10011-101C2	68.12	16.84	7.71	0.65	1.41	0.33	0.65
blood, adult, pool1	10053-101G8	88.59	15.50	2.21	2.21	0.00	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	39.39	12.85	5.14	0.86	0.86	0.00	0.00
bone marrow, adult	10192-103E3	46.56	20.92	12.15	2.02	2.70	0.00	0.00
brain, adult, donor1	10084-102B3	76.88	49.20	3.08	2.05	2.05	0.00	2.05
brain, adult, pool1	10012-101C3	59.13	44.43	6.01	0.56	0.78	0.11	0.11
brain, fetal, pool1	10085-102B4	128.23	114.87	5.34	0.00	0.00	0.00	2.67
breast carcinoma cell line:MCF7	10482-107A5	135.78	85.23	6.94	0.66	1.32	2.97	0.33
breast carcinoma cell line:MDA-MB-453	10419-106C5	70.03	206.46	2.62	0.25	0.12	2.00	0.25
breast, adult, donor1	10080-102A8	106.70	32.83	6.31	0.63	0.63	0.00	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	84.86	29.09	11.31	1.40	0.25	0.25	0.00
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	122.45	57.51	9.28	1.55	0.93	0.00	0.62
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	36.84	17.27	4.60	0.23	0.00	0.69	0.46
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	80.86	29.78	5.57	1.21	0.00	0.73	0.00
carcinoid cell line:NCI-H1770	10703-109H1	105.32	63.47	1.88	1.41	0.00	0.00	0.94
carcinoid cell line:NCI-H727	10735-110B6	125.02	37.96	12.58	1.53	1.31	1.31	0.11
carcinoid cell line:SK-PN-DW	10719-109I8	130.56	68.45	7.29	1.58	0.63	0.63	0.95
carcinosarcoma cell line:JHUCS-1	10642-109A3	106.74	151.46	26.88	2.13	2.13	0.80	1.86
caudate nucleus - adult, donor10196	10177-103C6	88.65	61.02	8.06	1.15	0.00	0.00	0.00
caudate nucleus, adult, donor10252	10164-103B2	78.31	49.53	3.85	0.50	0.84	0.33	0.17
caudate nucleus, adult, donor10258	10379-105H1	59.60	75.65	4.58	0.00	0.00	0.00	0.76
caudate nucleus, newborn, donor10223	10354-105E3	93.02	87.16	6.23	0.73	0.73	0.37	0.00
cerebellum - adult, donor10196	10173-103C2	198.10	253.45	11.65	0.00	2.91	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	215.22	188.53	11.74	1.49	0.64	0.21	0.00
cerebellum, adult, pool1	10083-102B2	114.52	73.82	8.28	0.69	0.69	0.00	0.69
cerebellum, newborn, donor10223	10357-105E6	162.74	151.11	13.28	0.00	0.83	0.83	0.00
cerebral meninges, adult	10188-103D8	64.30	23.95	3.78	0.50	0.50	0.25	0.00
cerebrospinal fluid, donor2	10294-104G6	41.66	37.28	1.46	0.73	1.46	0.73	0.73
cervical cancer cell line:D98-AH2	10552-107I3	72.90	30.63	13.23	0.86	0.86	0.86	0.29
cervical cancer cell line:ME-180	10553-107I4	62.81	41.59	5.30	0.50	0.00	0.50	0.66
cervix, adult, pool1	10013-101C4	63.41	26.56	7.45	1.68	0.84	0.00	1.47
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	44.87	19.65	2.37	0.42	0.84	0.14	0.42
chondrosarcoma cell line:SW 1353	10700-109G7	64.01	19.59	2.61	0.00	0.00	1.31	0.00
choriocarcinoma cell line:BeWo	10423-106C9	81.15	43.99	5.47	1.49	2.24	2.24	1.62
choriocarcinoma cell line:SCH	10785-110H2	59.27	41.77	0.74	0.49	0.25	0.62	0.62
choriocarcinoma cell line:T3M-3	10618-108G6	107.92	51.47	1.42	0.95	0.47	0.24	0.47
chorionic membrane cells, donor1	12238-129G6	35.33	8.83	2.56	0.28	0.00	0.28	0.28
chorionic membrane cells, donor2	12239-129G7	48.03	31.02	2.98	0.70	0.20	0.20	0.80
chorionic membrane cells, donor3	12240-129G8	50.55	14.29	4.40	0.55	1.10	0.00	0.55
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	31.30	64.63	13.13	0.00	8.08	1.01	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	70.88	39.19	13.83	1.15	1.92	1.15	0.19
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	94.40	41.18	15.21	1.27	2.11	0.21	0.21
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	96.81	124.81	12.07	1.80	0.51	1.80	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	98.44	131.82	9.68	1.45	1.45	0.73	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	90.40	116.26	12.42	5.09	1.43	1.63	0.41
chronic myelogenous leukemia cell line:K562	10454-106G4	89.81	107.77	7.95	0.29	0.88	0.59	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	106.86	46.91	16.68	1.04	0.52	1.04	0.78
clear cell carcinoma cell line:JHOC-5	10638-108I8	84.35	17.60	16.46	1.60	0.91	0.23	0.91
clear cell carcinoma cell line:TEN	10636-108I6	56.74	32.79	14.92	0.69	0.35	0.87	0.00
colon carcinoma cell line:CACO-2	10513-107D9	38.99	26.54	8.42	1.28	1.65	2.93	0.37
colon carcinoma cell line:COLO-320	10420-106C6	148.61	144.05	8.36	0.38	0.38	1.14	0.76
colon, adult, donor1	10082-102B1	116.62	63.07	3.57	0.00	0.00	0.00	1.19
colon, adult, pool1	10014-101C5	69.44	18.92	7.64	1.53	1.29	0.35	4.23
colon, fetal, donor1	10070-101I7	134.72	11.12	9.89	1.85	0.62	0.00	0.62
common myeloid progenitor CMP, donor1	12130-128D6	169.59	64.17	114.59	4.58	18.33	9.17	0.00
common myeloid progenitor CMP, donor2	12134-128E1	0.00	25.04	25.04	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	44.19	28.90	80.31	11.05	11.05	0.42	0.42
cord blood derived cell line:COBL-a 24h infection	10453-106G3	44.52	30.19	86.48	9.36	7.85	0.75	9.36
cord blood derived cell line:COBL-a untreated	10449-106F8	44.28	30.60	66.56	8.74	4.94	0.71	0.00
corpus callosum, adult, pool1	10042-101F6	83.59	63.13	8.73	0.11	0.77	0.22	0.22
cruciate ligament, donor2	10295-104G7	79.43	18.64	3.24	1.62	0.81	0.00	0.00
diaphragm, fetal, donor1	10069-101I6	81.06	43.34	0.80	0.00	0.00	0.00	0.00
diencephalon, adult	10193-103E4	44.40	25.20	4.08	0.00	0.48	0.24	0.00
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	81.28	88.86	8.04	0.92	1.61	1.15	1.15
ductal cell carcinoma cell line:KLM-1	10438-106E6	44.36	26.41	4.10	1.80	0.26	1.03	0.26
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	57.05	24.07	5.54	3.61	2.41	0.24	0.00
ductus deferens, adult	10196-103E7	79.73	19.93	6.48	1.00	0.50	0.00	0.50
duodenum, fetal, donor1, tech_rep1	10071-101I8	126.74	43.21	2.88	2.88	0.00	1.44	1.44
duodenum, fetal, donor1, tech_rep2	10071-101I8	83.13	45.61	10.30	1.47	0.00	0.74	0.00
dura mater, adult, donor1	10041-101F5	53.19	27.09	6.28	0.99	0.50	0.25	0.17
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	58.41	136.57	22.43	2.89	5.33	4.00	4.44
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	50.30	63.19	16.34	3.58	2.44	0.57	1.00
embryonic pancreas cell line:1B2C6	10604-108F1	116.54	48.10	1.23	0.00	0.00	1.23	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	75.07	29.67	6.05	0.30	0.61	0.30	0.30
embryonic pancreas cell line:1C3IKEI	10606-108F3	96.33	50.02	2.16	0.62	0.93	0.62	0.00
embryonic pancreas cell line:2C6	10603-108E9	131.35	39.40	7.88	0.00	2.63	1.31	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	82.79	70.73	24.80	2.01	2.01	0.67	0.67
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	62.16	25.92	6.34	0.72	0.72	0.18	0.18
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	21.23	14.96	1.29	0.16	0.16	0.00	0.00
epidermoid carcinoma cell line:A431	10426-106D3	82.59	34.01	4.89	2.11	0.44	1.33	0.67
epidermoid carcinoma cell line:Ca Ski	10431-106D8	48.50	18.59	6.38	1.43	0.88	0.99	0.11
epididymis, adult	10197-103E8	76.61	18.63	6.28	1.88	1.26	0.21	1.05
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	67.42	37.79	4.44	1.24	1.06	0.53	0.00
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	83.76	12.58	13.37	1.57	1.18	0.39	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	57.53	131.05	6.95	0.92	0.52	1.44	0.13
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	72.73	110.33	7.28	1.28	0.69	1.28	0.10
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	58.82	124.46	6.72	0.90	0.22	1.23	0.11
esophagus, adult, pool1	10015-101C6	51.81	21.13	4.35	0.85	0.96	0.11	0.53
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	99.19	52.47	40.33	7.01	2.50	0.63	2.13
eye - muscle inferior rectus, donor1	10272-104E2	144.87	45.88	12.07	2.41	4.83	0.00	4.83
eye - muscle lateral, donor2	10298-104H1	42.08	23.15	2.10	0.00	2.10	0.00	0.00
eye - muscle medial, donor2	10299-104H2	95.25	28.28	1.49	0.00	0.00	2.98	0.00
eye - muscle superior, donor2	10297-104G9	79.11	25.22	0.00	0.00	0.00	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	61.21	23.32	5.83	0.00	0.00	0.00	0.00
eye, fetal, donor1	10054-101G9	53.39	23.64	6.86	0.00	0.51	2.03	0.00
fibrosarcoma cell line:HT-1080	10758-110E2	65.65	28.08	5.64	1.15	0.51	0.13	0.38
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	78.59	32.53	6.17	1.90	0.95	0.71	0.24
frontal lobe, adult, pool1	10040-101F4	59.77	47.85	5.54	1.03	0.28	0.09	0.47
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	74.16	15.01	15.31	2.10	1.20	0.30	0.90
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	53.22	19.48	9.69	0.82	1.01	0.82	0.09
gall bladder, adult	10198-103E9	85.47	17.87	5.31	1.93	0.97	0.00	0.72
gamma delta positive T cells, donor1	11937-126A2	78.38	19.33	9.66	1.61	1.07	0.00	1.07
gamma delta positive T cells, donor2	11938-126A3	65.36	18.67	14.94	3.36	1.87	0.37	0.37
gastric adenocarcinoma cell line:MKN1	10614-108G2	52.17	47.10	4.86	1.06	0.84	0.21	1.06
gastric adenocarcinoma cell line:MKN45	10612-108F9	128.43	70.02	10.83	1.93	0.77	0.19	0.77
gastric cancer cell line:AZ521	10549-107H9	84.27	59.52	7.87	2.13	1.80	0.16	0.16
gastric cancer cell line:GSS	10560-108A2	147.35	49.42	10.98	0.92	0.92	0.92	2.75
gastrointestinal carcinoma cell line:ECC12	10615-108G3	84.07	51.40	8.68	1.37	0.69	1.83	2.06
giant cell carcinoma cell line:LU65	10487-107B1	29.60	44.63	2.75	0.23	0.57	1.72	0.23
giant cell carcinoma cell line:Lu99B	10433-106E1	71.52	18.47	8.26	1.82	1.26	0.14	0.28
glassy cell carcinoma cell line:HOKUG	10688-109F4	110.24	23.94	6.73	0.25	1.00	0.75	0.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	43.07	46.76	2.32	0.42	0.00	0.42	0.21
glioblastoma cell line:A172, tech_rep2	10444-106F3	47.33	46.77	1.97	0.56	0.00	0.14	0.14
glioblastoma cell line:T98G	10485-107A8	57.73	21.19	5.52	1.32	0.44	0.55	0.00
glioma cell line:GI-1	10413-106B8	81.13	21.38	6.44	1.17	1.17	0.59	0.88
globus pallidus - adult, donor10196	10175-103C4	96.95	80.18	2.19	0.73	0.00	0.00	0.00
globus pallidus, adult, donor10252	10161-103A8	100.08	98.13	6.10	0.24	0.49	0.24	0.24
globus pallidus, adult, donor10258	10367-105F7	34.23	53.40	4.11	0.00	1.37	1.37	0.00
globus pallidus, newborn, donor10223	10364-105F4	64.48	54.36	3.20	0.53	1.07	0.53	0.53
granulocyte macrophage progenitor, donor1	12131-128D7	198.22	66.07	70.97	0.00	12.24	2.45	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	21.86	21.86	32.79	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	5.23	31.36	20.91	0.00	10.45	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	46.40	28.48	2.88	0.32	0.32	0.00	0.32
hIPS +CCl2, biol_rep1	14383-156B9	47.75	96.87	7.80	1.38	0.46	5.97	0.46
hIPS +CCl2, biol_rep2	14384-156C1	40.70	87.34	5.03	0.46	0.46	6.86	0.46
hIPS +CCl2, biol_rep3	14385-156C2	49.60	117.87	7.09	0.64	0.64	5.80	0.00
hIPS, biol_rep1	14380-156B6	43.12	159.54	2.87	0.00	1.44	7.19	0.00
hIPS, biol_rep2	14381-156B7	61.04	115.91	4.80	1.37	0.00	5.49	0.00
hIPS, biol_rep3	14382-156B8	54.07	75.04	3.31	0.00	1.10	2.21	0.00
hairy cell leukemia cell line:Mo	10712-109I1	70.97	49.14	16.09	4.02	1.72	1.15	0.86
heart - mitral valve, adult	10205-103F7	67.87	17.64	4.48	0.90	1.20	0.30	0.30
heart - pulmonic valve, adult	10206-103F8	65.11	32.68	6.01	0.26	0.52	0.26	0.00
heart - tricuspid valve, adult	10207-103F9	149.88	34.14	9.99	1.67	0.00	0.83	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	54.07	40.40	4.29	0.20	0.00	0.41	0.20
heart, adult, diseased, donor1	10051-101G6	61.75	46.84	3.41	0.00	0.00	0.85	0.00
heart, adult, pool1	10016-101C7	32.43	17.48	3.45	0.46	0.00	0.00	0.23
heart, fetal, pool1	10046-101G1	63.87	33.37	8.63	0.21	0.62	0.21	0.31
hepatic mesenchymal tumor cell line:LI90	10778-110G4	66.64	10.49	1.23	0.31	0.31	0.00	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	140.32	110.59	5.95	0.00	0.00	1.19	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	101.77	106.96	6.30	0.77	0.99	2.43	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	97.46	101.71	6.92	1.46	0.73	1.70	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	105.20	119.85	7.28	1.01	1.01	3.13	0.10
hepatoma cell line:Li-7	10484-107A7	46.71	30.36	3.89	0.67	0.11	0.67	0.22
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	81.41	48.44	6.93	1.71	0.70	2.01	0.20
hippocampus - adult, donor10196	10169-103B7	80.44	70.03	2.84	0.00	0.95	0.00	0.00
hippocampus, adult, donor10252	10153-102I9	119.81	61.84	3.47	1.22	0.20	0.20	0.00
hippocampus, adult, donor10258	10374-105G5	49.30	77.68	3.98	0.00	0.50	0.00	0.00
hippocampus, newborn, donor10223	10363-105F3	85.30	59.57	7.75	1.41	1.06	0.35	1.06
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	50.66	67.14	7.93	0.61	0.61	4.88	0.61
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	43.79	36.52	5.69	0.98	0.39	2.95	1.18
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	46.21	45.96	7.62	0.25	1.27	3.30	1.02
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	129.69	121.23	18.61	4.51	2.82	2.26	5.07
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	128.59	100.19	20.40	5.42	1.29	3.87	5.16
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	82.00	84.65	20.50	2.66	1.52	1.90	4.56
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	91.09	101.02	23.06	4.67	2.34	2.63	2.63
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	106.42	70.66	16.59	3.88	0.65	2.59	3.23
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	85.08	84.67	22.52	2.50	0.83	1.25	2.92
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	33.86	44.04	20.36	1.18	1.18	1.66	1.89
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	68.47	68.79	21.54	2.73	1.77	3.38	2.25
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	51.17	50.50	14.14	2.69	0.67	0.67	0.67
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	41.94	47.57	8.14	0.47	0.78	5.79	0.94
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	38.32	59.94	6.39	0.98	0.49	6.39	1.97
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	21.82	66.33	8.73	0.87	1.75	7.85	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	136.69	113.97	35.13	4.58	4.01	5.54	5.92
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	124.28	142.60	34.89	8.29	5.23	3.05	3.05
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	128.94	197.41	30.99	8.50	3.50	5.50	7.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	85.53	54.07	25.62	2.64	1.32	0.94	3.20
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	92.31	63.21	27.74	3.64	2.73	0.91	2.27
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	92.72	68.60	29.13	4.39	0.31	0.94	0.94
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	54.71	57.48	19.43	2.45	1.80	1.14	1.14
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	46.16	49.64	19.45	0.87	2.03	2.03	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	79.21	93.56	24.21	3.89	1.79	4.48	1.49
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	44.52	71.50	8.87	1.29	0.55	7.02	0.74
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	53.63	75.03	9.98	0.86	3.14	3.99	0.57
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	56.76	110.65	7.76	0.41	0.82	6.12	0.82
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	75.70	127.81	23.24	4.93	1.41	2.11	5.63
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	71.27	103.26	18.69	2.85	1.58	1.58	3.17
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	77.47	134.36	20.58	3.93	1.21	1.21	3.33
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	64.12	70.33	16.55	0.52	1.03	1.55	5.69
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	55.13	62.43	17.27	1.33	1.99	1.33	3.32
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	44.64	44.38	18.73	1.03	2.31	1.54	2.05
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	43.46	63.66	14.57	2.56	1.28	0.26	0.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	39.38	67.39	24.99	1.51	1.51	1.51	0.76
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	52.09	87.37	19.49	2.69	1.34	1.34	2.02
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	54.34	78.25	8.45	2.17	1.45	4.83	1.69
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	49.91	98.94	10.25	1.78	0.89	7.13	2.23
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	63.90	108.78	11.22	1.46	2.44	5.85	1.95
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	101.77	129.58	24.14	2.75	2.44	3.97	3.06
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	87.84	286.29	19.52	9.76	9.76	9.76	22.77
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	90.02	153.89	18.20	3.31	2.65	2.98	4.96
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	61.30	87.02	22.44	0.55	0.55	1.09	2.19
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	78.53	76.00	18.82	3.62	1.45	2.17	2.53
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	60.50	75.44	24.20	3.20	2.14	1.42	2.85
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	46.54	89.50	10.74	1.19	1.19	1.19	1.19
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	62.43	89.25	26.14	2.98	1.90	2.57	2.57
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	57.65	108.03	20.20	1.62	0.81	1.89	1.08
immature langerhans cells, donor1	11904-125F5	58.60	100.25	41.65	15.98	6.78	1.21	0.24
immature langerhans cells, donor2	11905-125F6	65.75	70.50	16.63	0.79	0.00	0.00	0.00
insula, adult, pool1	10039-101F3	70.41	51.67	5.77	0.85	0.19	0.19	0.57
keratoacanthoma cell line:HKA-1	10791-110H8	76.08	47.15	1.30	0.00	0.00	0.33	0.65
kidney, adult, pool1	10017-101C8	45.06	32.34	3.20	0.80	0.30	0.00	0.90
kidney, fetal, pool1	10045-101F9	61.04	38.90	5.73	0.21	0.28	0.57	1.20
large cell lung carcinoma cell line:IA-LM	10509-107D5	124.98	40.19	49.85	3.12	8.95	0.85	1.70
large cell lung carcinoma cell line:NCI-H460	10839-111E2	45.21	31.80	3.46	0.00	0.41	0.28	0.14
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	54.13	8.99	4.59	1.10	0.37	0.73	0.00
left atrium, adult, donor1	10079-102A7	45.22	56.66	2.18	0.54	0.00	0.00	0.00
left ventricle, adult, donor1	10078-102A6	55.12	18.71	2.53	0.51	0.00	0.00	0.00
leiomyoblastoma cell line:G-402	10721-110A1	129.69	70.04	4.38	3.01	1.09	0.55	0.00
leiomyoma cell line:10964C	10569-108B2	21.20	16.17	1.80	1.08	0.36	0.36	0.00
leiomyoma cell line:15242A	10570-108B3	14.13	8.70	1.63	0.00	0.00	0.00	0.00
leiomyoma cell line:15425	10571-108B4	22.58	17.48	2.91	0.97	0.73	0.00	0.73
leiomyosarcoma cell line:Hs 5.T	10722-110A2	12.70	0.00	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	62.73	48.10	7.32	0.00	0.00	3.14	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	98.93	37.19	10.98	0.83	1.77	1.53	0.24
liposarcoma cell line:KMLS-1	10782-110G8	36.87	10.15	2.50	0.00	0.47	0.16	0.16
liposarcoma cell line:SW 872	10726-110A6	79.20	42.77	4.87	1.22	0.61	1.22	0.12
liver, adult, pool1	10018-101C9	40.52	27.39	1.94	1.13	1.13	0.16	0.65
liver, fetal, pool1	10086-102B5	80.90	29.16	2.82	0.94	0.00	0.00	0.94
locus coeruleus - adult, donor10196	10182-103D2	94.35	59.64	3.06	0.58	0.29	0.44	0.00
locus coeruleus, adult, donor10252	10165-103B3	76.22	59.43	3.14	0.74	0.18	0.55	0.00
locus coeruleus, adult, donor10258	10375-105G6	72.23	41.76	2.82	0.56	0.28	0.00	0.00
locus coeruleus, newborn, donor10223	10362-105F2	50.05	89.59	4.21	1.26	0.42	0.84	0.42
lung adenocarcinoma cell line:A549	10499-107C4	57.57	22.42	2.35	0.14	0.28	0.28	0.42
lung adenocarcinoma cell line:PC-14	10408-106B3	84.11	147.53	4.83	0.00	0.00	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	158.31	58.66	19.38	2.24	2.37	0.66	0.40
lung, adult, pool1	10019-101D1	64.26	21.74	5.55	1.77	1.77	0.12	1.54
lung, fetal, donor1	10068-101I5	110.17	57.94	20.83	0.57	2.28	0.29	0.29
lung, right lower lobe, adult, donor1	10075-102A3	152.13	26.58	9.16	3.67	4.58	0.00	3.21
lymph node, adult, donor1	10077-102A5	81.89	30.30	4.73	0.95	0.47	0.00	1.89
lymphangiectasia cell line:DS-1	10727-110A7	109.81	34.85	5.26	0.88	1.10	0.22	0.44
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	62.48	31.69	13.89	1.66	1.51	0.30	0.45
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	44.17	53.52	1.70	1.70	0.00	1.70	0.85
mature adipocyte, donor1	12231-129F8	33.30	16.43	3.11	0.00	0.89	0.00	0.00
mature adipocyte, donor2	12232-129F9	39.22	8.09	2.08	0.00	0.00	0.00	0.21
mature adipocyte, donor3	12233-129G1	25.37	14.46	2.61	0.00	0.47	0.00	0.00
mature adipocyte, donor4	12234-129G2	42.64	11.06	2.63	0.26	0.26	0.00	0.53
maxillary sinus tumor cell line:HSQ-89	10414-106B9	193.70	113.41	8.58	2.86	1.67	2.62	0.95
medial frontal gyrus - adult, donor10196	10170-103B8	69.94	69.94	4.51	1.13	0.00	0.00	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	122.11	72.09	4.60	0.18	0.74	0.55	0.00
medial frontal gyrus, adult, donor10258	10368-105F8	72.12	107.06	3.81	0.32	0.95	0.32	0.32
medial frontal gyrus, newborn, donor10223	10352-105E1	67.39	73.78	1.28	0.85	0.43	0.00	0.00
medial temporal gyrus - adult, donor10196	10183-103D3	93.66	79.65	3.88	0.34	0.51	0.34	0.00
medial temporal gyrus, adult, donor10252	10156-103A3	130.94	87.86	4.24	0.64	0.42	0.21	0.21
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	40.45	107.87	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	86.12	43.06	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	87.94	60.30	4.67	2.15	0.36	0.36	0.00
medulla oblongata - adult, donor10196	10174-103C3	83.07	56.46	3.24	0.00	0.00	0.65	1.95
medulla oblongata, adult, donor10252	10155-103A2	79.72	65.95	4.80	0.46	0.00	0.46	0.00
medulla oblongata, adult, pool1	10038-101F2	57.14	42.12	5.31	0.41	0.16	0.16	0.00
medulla oblongata, newborn, donor10223	10361-105F1	71.87	51.04	6.25	1.39	0.35	0.35	1.04
medulloblastoma cell line:D283 Med	10838-111E1	143.70	138.38	14.83	1.99	1.11	5.31	1.11
medulloblastoma cell line:ONS-76	10759-110E3	102.59	49.89	8.31	1.59	1.71	0.73	0.12
melanoma cell line:COLO 679	10514-107E1	41.54	30.19	8.77	1.58	3.16	0.57	2.59
melanoma cell line:G-361	10465-106H6	52.12	23.07	6.79	1.09	1.63	0.54	3.80
meningioma cell line:HKBMM	10691-109F7	72.00	9.23	6.51	0.72	0.72	0.18	0.36
merkel cell carcinoma cell line:MKL-1	10843-111E6	123.36	225.58	11.46	3.52	0.00	1.76	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	119.76	167.46	20.48	2.33	2.07	2.33	0.26
mesenchymal precursor cell - adipose, donor1	11747-123G1	36.82	18.41	1.99	0.61	0.31	0.00	0.15
mesenchymal precursor cell - adipose, donor2	11748-123G2	27.63	20.36	1.82	0.55	0.55	0.00	0.36
mesenchymal precursor cell - adipose, donor3	11749-123G3	24.02	41.82	1.66	1.24	0.41	0.00	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	27.95	9.55	1.40	0.42	0.42	0.00	0.14
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	25.80	25.61	0.19	0.39	0.39	0.00	0.00
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	16.66	14.58	0.69	0.00	0.69	0.00	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	32.10	9.44	1.20	0.86	0.00	0.17	0.69
mesenchymal precursor cell - cardiac, donor2	11753-123G7	32.32	21.74	2.42	0.46	0.46	0.23	0.46
mesenchymal precursor cell - cardiac, donor3	11754-123G8	26.26	33.03	1.06	0.40	0.66	0.13	0.00
mesenchymal precursor cell - cardiac, donor4	11755-123G9	23.23	9.32	2.30	0.27	0.00	0.14	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	29.02	14.08	1.56	0.14	0.00	0.14	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	36.56	17.13	3.29	1.32	0.33	0.00	1.32
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	31.96	16.60	1.25	0.69	0.14	0.14	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	28.62	12.57	1.40	0.35	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	22.46	6.94	2.04	0.61	0.41	0.00	0.41
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	26.60	17.25	2.16	1.08	0.00	0.00	0.72
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	24.52	6.72	1.34	0.31	0.31	0.10	0.10
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	14.59	9.80	2.05	0.23	0.46	0.23	0.23
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	20.14	5.87	1.26	0.00	0.00	0.00	0.42
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	28.24	13.45	1.49	1.34	0.15	0.00	0.15
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	26.78	12.17	1.49	0.44	0.44	0.00	0.09
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	40.13	12.15	2.21	0.37	0.37	0.00	0.74
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	26.04	12.59	2.00	1.43	0.00	0.00	0.29
mesenchymal stem cell line:Hu5/E18	10568-108B1	46.31	34.94	2.11	0.00	0.84	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	19.64	18.72	2.74	0.00	0.91	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	21.74	17.65	0.77	0.77	0.26	0.26	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	21.73	19.63	1.31	0.00	0.26	0.26	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	28.34	21.57	2.46	0.00	0.92	0.00	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	20.01	20.01	1.88	0.24	0.71	0.24	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	22.00	27.08	3.05	0.34	0.00	0.00	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	20.83	22.79	1.96	0.00	0.00	0.39	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	23.63	14.83	2.32	0.46	0.00	0.00	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	48.30	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	25.09	27.40	2.31	0.29	0.58	0.00	0.58
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	24.32	22.53	0.89	0.22	0.45	0.00	0.67
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	24.52	17.55	2.40	0.72	0.24	0.00	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	27.87	34.47	0.73	0.00	1.47	0.73	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	20.48	15.10	1.68	0.34	0.00	0.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	21.29	18.42	0.82	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	19.76	20.19	1.29	0.86	0.43	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	19.14	19.14	5.47	0.00	0.00	2.73	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	10.33	30.99	5.16	0.00	0.00	0.00	5.16
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	18.19	16.89	0.97	0.00	0.32	0.00	0.32
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	26.19	18.91	4.36	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	20.79	26.12	0.53	0.00	0.53	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	13.08	18.81	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	17.10	15.94	1.17	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	16.79	23.09	4.20	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	11.92	11.92	1.99	0.00	0.00	0.00	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	9.53	9.53	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	17.79	17.79	1.19	0.00	0.00	0.00	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	10.97	15.84	1.22	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	54.10	27.05	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	16.47	20.90	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	9.31	21.38	1.03	0.34	0.00	0.34	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	10.75	6.45	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	15.97	15.97	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	20.66	24.11	3.44	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	20.78	26.49	1.22	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	26.22	21.45	1.59	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	14.15	34.19	2.36	0.00	0.00	0.00	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	17.46	40.83	1.56	0.00	0.00	0.00	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	10.69	36.09	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	22.47	49.67	3.55	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	15.41	56.50	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	28.91	46.81	3.44	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	16.82	66.30	1.98	0.00	0.00	0.49	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	12.34	68.41	2.24	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	20.35	65.51	1.27	0.00	0.00	0.64	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	17.73	94.70	1.21	0.00	0.00	0.40	0.40
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	15.26	87.22	2.18	2.18	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	8.87	105.17	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	25.49	43.70	0.61	0.00	0.00	0.00	0.61
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	9.04	76.82	0.00	9.04	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	28.83	47.77	0.00	0.00	0.00	0.00	0.82
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	15.08	51.19	1.98	0.00	0.00	0.40	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	19.15	38.61	0.97	0.00	0.00	0.00	0.32
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	16.30	45.84	2.04	0.00	0.00	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	55.71	21.66	0.00	0.00	0.77	1.55	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	117.41	52.45	1.42	0.94	0.47	0.94	0.94
mesothelioma cell line:ACC-MESO-4	10494-107B8	49.81	37.76	3.71	0.46	0.46	0.23	0.00
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	34.19	25.64	4.27	0.00	8.55	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	38.74	42.44	3.60	0.62	0.00	0.62	0.21
mesothelioma cell line:Mero-25	10850-111F4	88.06	37.67	14.53	1.82	3.86	1.82	0.23
mesothelioma cell line:Mero-41	10851-111F5	66.74	165.51	7.82	2.20	0.24	0.00	0.73
mesothelioma cell line:Mero-48a	10852-111F6	43.18	71.52	3.10	0.22	0.22	0.00	0.22
mesothelioma cell line:Mero-82	10853-111F7	59.66	36.00	9.20	1.84	0.79	1.84	0.26
mesothelioma cell line:Mero-83	10854-111F8	34.55	90.05	3.23	0.85	0.34	0.85	1.02
mesothelioma cell line:Mero-84	10855-111F9	31.09	21.74	4.30	0.51	1.26	0.25	0.25
mesothelioma cell line:Mero-95	10856-111G1	44.51	31.06	3.31	1.04	0.62	0.21	0.83
mesothelioma cell line:NCI-H2052	10847-111F1	29.65	30.98	4.47	0.50	1.16	0.33	0.00
mesothelioma cell line:NCI-H226	10846-111E9	31.13	35.29	7.42	1.27	1.27	0.54	0.54
mesothelioma cell line:NCI-H2452	10848-111F2	32.29	28.01	1.88	0.68	0.00	0.17	0.00
mesothelioma cell line:NCI-H28	10845-111E8	48.35	35.37	3.56	0.51	0.25	1.27	0.25
mesothelioma cell line:No36	10857-111G2	37.51	44.36	7.50	0.65	0.00	1.63	0.00
mesothelioma cell line:ONE58	10858-111G3	22.76	27.64	4.06	0.81	0.27	1.08	0.00
migratory langerhans cells, donor1	11901-125F2	50.48	16.12	4.03	0.96	0.58	0.00	0.19
migratory langerhans cells, donor2	11902-125F3	51.17	9.89	5.13	0.37	0.37	0.12	0.49
migratory langerhans cells, donor3	11903-125F4	51.15	17.95	4.85	0.54	0.54	0.00	0.00
mixed mullerian tumor cell line:HTMMT	10689-109F5	51.26	11.75	3.59	1.96	1.31	0.33	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	47.47	23.31	5.30	0.42	0.64	0.85	0.21
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	157.10	31.79	6.68	1.84	0.46	0.92	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	40.15	31.78	23.22	4.00	1.33	0.19	1.14
myelodysplastic syndrome cell line:SKM-1	10772-110F7	103.11	69.11	15.34	2.03	1.66	0.18	0.00
myeloma cell line:PCM6	10474-106I6	79.46	15.02	20.95	1.98	2.57	0.20	0.40
myxofibrosarcoma cell line:MFH-ino	10600-108E6	109.07	41.60	4.06	0.00	1.01	0.51	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	47.66	37.46	6.86	0.59	0.98	0.59	0.39
nasal epithelial cells, donor1, tech_rep1	12226-129F3	33.54	11.37	1.11	0.22	0.00	0.00	0.11
nasal epithelial cells, donor1, tech_rep2	12226-129F3	34.27	13.46	1.62	0.22	0.15	0.22	0.15
nasal epithelial cells, donor2	12227-129F4	62.37	18.22	2.21	0.55	0.55	0.00	0.00
neuroblastoma cell line:CHP-134	10508-107D4	173.47	97.55	15.87	2.99	1.15	0.92	0.23
neuroblastoma cell line:NB-1	10539-107G8	124.60	26.94	20.02	1.87	3.18	1.31	0.00
neuroblastoma cell line:NBsusSR	10607-108F4	47.03	59.89	3.80	1.27	0.63	0.63	1.27
neuroblastoma cell line:NH-12	10555-107I6	157.65	112.18	8.57	1.86	0.56	2.98	0.37
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	129.29	165.11	6.17	0.95	0.71	0.47	0.71
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	130.98	102.63	9.03	4.43	1.27	1.58	1.58
neuroectodermal tumor cell line:TASK1	10774-110F9	52.13	37.23	6.44	0.81	0.60	0.00	0.40
neuroepithelioma cell line:SK-N-MC	10728-110A8	204.72	150.04	5.09	2.54	1.27	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	62.02	13.84	2.66	0.00	0.27	0.27	0.00
neutrophil PMN, donor1	12133-128D9	74.37	0.00	59.50	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	39.84	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	18.94	9.47	28.41	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	184.85	49.21	31.46	4.23	3.38	0.85	0.51
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	42.43	35.22	1.60	1.60	0.80	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	37.51	28.85	3.53	0.00	0.32	0.32	0.32
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	32.06	16.82	2.89	0.26	0.26	0.00	0.00
nucleus accumbens, adult, pool1	10037-101F1	64.87	44.71	4.03	0.94	0.28	0.28	0.19
occipital cortex - adult, donor10196	10172-103C1	107.14	129.80	0.00	0.00	0.00	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	157.53	102.78	6.17	0.81	0.54	0.81	0.27
occipital cortex, newborn, donor10223	10355-105E4	86.25	56.41	5.10	1.09	0.36	0.73	0.00
occipital lobe, adult, donor1	10076-102A4	104.17	56.15	7.87	2.89	1.57	0.52	2.36
occipital lobe, fetal, donor1	10073-102A1	168.21	75.95	3.00	0.86	0.00	2.57	0.86
occipital pole, adult, pool1	10036-101E9	67.09	50.38	4.26	0.47	0.32	0.00	0.63
olfactory region, adult	10195-103E6	94.00	55.02	4.20	1.34	0.38	0.00	0.38
optic nerve, donor1	10277-104E7	146.08	54.03	8.00	0.00	0.00	0.00	2.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	72.45	42.72	3.99	1.71	0.68	1.48	1.25
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	57.29	28.99	1.37	0.41	0.14	1.92	0.14
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	41.99	21.33	6.94	0.68	0.17	1.02	0.34
oral squamous cell carcinoma cell line:SAS	10544-107H4	50.36	25.64	6.70	1.27	0.69	0.35	0.46
osteoclastoma cell line:Hs 706.T	10704-109H2	54.97	17.05	3.23	0.00	0.29	0.00	1.47
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	135.48	59.80	17.75	1.87	6.54	1.87	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	42.20	34.99	9.33	3.39	1.70	0.85	0.21
ovary, adult, pool1	10020-101D2	54.33	23.24	5.59	0.96	1.66	0.26	0.44
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	70.94	36.11	4.77	1.28	0.92	0.55	0.18
pancreas, adult, donor1	10049-101G4	78.07	25.40	0.94	0.00	0.00	0.00	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	136.13	58.98	3.91	1.40	0.84	2.52	1.68
papillary adenocarcinoma cell line:8505C	10437-106E5	40.20	15.16	2.73	0.51	0.51	0.85	0.00
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	94.88	50.01	9.93	1.32	0.66	1.66	0.50
paracentral gyrus, adult, pool1	10035-101E8	59.58	42.47	5.40	0.73	0.09	0.55	0.37
parietal cortex, adult, donor10258	10373-105G4	81.47	53.58	2.94	1.47	1.47	0.00	0.00
parietal lobe - adult, donor10196	10171-103B9	81.82	63.95	4.70	2.82	0.94	0.00	0.00
parietal lobe, adult, donor10252	10157-103A4	114.58	75.25	2.28	0.57	1.14	0.00	0.00
parietal lobe, adult, pool1	10034-101E7	70.06	47.50	4.85	0.53	0.18	0.09	0.44
parietal lobe, fetal, donor1	10072-101I9	167.78	193.97	7.76	0.97	0.00	2.91	0.00
parietal lobe, newborn, donor10223	10356-105E5	81.88	59.44	5.98	1.50	0.00	0.37	0.37
parotid gland, adult	10199-103F1	52.42	9.25	3.70	0.00	0.62	0.00	0.00
penis, adult	10200-103F2	50.49	15.04	9.13	2.15	1.07	0.00	0.54
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	152.65	29.75	6.88	1.67	0.74	0.93	0.93
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	79.11	21.42	4.52	0.87	0.73	0.73	0.73
pineal gland - adult, donor10196	10179-103C8	108.36	175.45	10.97	0.65	1.29	10.32	0.00
pineal gland, adult, donor10252	10160-103A7	107.19	191.28	12.44	0.59	0.59	19.54	0.00
pineal gland, adult, donor10258	10377-105G8	82.77	170.56	8.15	0.00	1.25	3.76	0.00
pituitary gland - adult, donor10196	10180-103C9	96.12	82.97	4.05	0.00	1.01	1.01	0.00
pituitary gland, adult, donor10252	10162-103A9	133.94	123.52	13.55	0.00	2.08	1.56	1.04
pituitary gland, adult, donor10258	10378-105G9	91.93	137.90	10.21	0.85	0.00	0.00	0.00
placenta, adult, pool1	10021-101D3	80.09	28.92	6.45	0.65	0.65	0.22	0.65
plasma cell leukemia cell line:ARH-77	10840-111E3	74.56	34.30	12.71	3.18	1.46	0.79	0.26
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	42.96	17.59	2.80	0.47	0.16	0.78	0.16
pons, adult, pool1	10033-101E6	49.06	37.10	4.39	0.52	0.00	0.34	0.43
postcentral gyrus, adult, pool1	10032-101E5	61.37	48.64	5.14	0.44	0.44	0.09	0.61
promyelocytes/myelocytes PMC, donor1	12132-128D8	92.02	23.01	56.47	0.00	8.37	4.18	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	22.03	44.06	5.51	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	23.47	0.00	35.21	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	44.57	12.09	7.14	0.00	1.60	0.87	0.00
prostate cancer cell line:PC-3	10439-106E7	63.34	56.81	7.62	0.54	1.09	0.54	0.00
prostate, adult, pool1	10022-101D4	57.50	18.77	5.53	0.54	0.45	0.27	0.82
putamen, adult, donor10196	10176-103C5	76.48	51.23	4.49	0.24	0.00	0.24	0.00
putamen, adult, donor10252	10152-102I8	78.43	33.33	11.76	0.00	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	38.25	98.35	2.19	0.00	0.00	2.19	1.09
putamen, adult, donor10258, tech_rep2	10372-105G3	64.03	53.40	2.66	0.72	0.24	0.00	0.00
putamen, newborn, donor10223	10365-105F5	51.73	77.22	3.00	3.00	0.00	0.00	0.00
rectal cancer cell line:TT1TKB	10469-106I1	109.97	45.39	10.18	2.04	0.87	2.62	0.29
rectum, fetal, donor1	10067-101I4	183.61	29.21	8.35	1.39	0.00	1.39	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	43.46	22.26	5.30	0.42	0.42	0.21	0.00
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	68.76	7.04	9.11	0.41	0.00	0.00	0.00
retina, adult, pool1	10030-101E3	60.53	45.52	10.44	0.70	0.40	2.39	1.29
retinoblastoma cell line:Y79	10475-106I7	85.73	79.24	18.97	0.78	0.78	8.57	0.26
rhabdomyosarcoma cell line:KYM-1	10787-110H4	74.26	38.48	13.89	3.57	0.86	0.61	0.37
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	139.19	95.89	37.96	6.19	9.28	1.41	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	88.67	17.43	1.52	0.76	0.76	0.00	0.00
salivary acinar cells, donor1	11771-123I7	46.94	28.16	3.56	0.97	0.00	0.00	1.13
salivary acinar cells, donor2	11772-123I8	43.65	39.93	9.36	0.83	1.24	0.00	1.65
salivary acinar cells, donor3	11773-123I9	128.44	76.14	5.30	0.00	0.00	0.00	0.66
salivary gland, adult, pool1	10093-102C3	45.18	22.88	6.29	1.72	0.00	0.00	0.57
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	68.88	45.28	11.38	2.45	1.60	0.08	0.25
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	80.05	51.61	6.82	1.06	0.71	0.35	0.82
seminal vesicle, adult	10201-103F3	104.23	37.03	12.70	0.53	1.59	0.00	1.06
serous adenocarcinoma cell line:JHOS-2	10639-108I9	42.03	33.04	7.53	0.97	0.00	0.73	0.73
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	27.93	28.43	2.52	0.75	0.25	0.25	0.50
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	30.11	44.16	1.00	1.00	0.00	0.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	61.25	28.07	4.43	0.40	0.54	0.67	0.27
signet ring carcinoma cell line:Kato III	10436-106E4	62.01	38.68	5.86	0.77	0.77	0.77	0.33
signet ring carcinoma cell line:NUGC-4	10483-107A6	68.77	34.71	7.48	1.03	1.03	0.77	0.52
skeletal muscle - soleus muscle, donor1	10282-104F3	49.65	26.25	0.00	1.42	0.00	0.00	0.00
skeletal muscle, adult, pool1	10023-101D5	53.85	26.75	4.20	1.20	1.20	0.00	0.96
skeletal muscle, fetal, donor1	10066-101I3	72.36	81.41	3.02	0.00	0.00	0.00	1.01
skin, adult, donor1	10074-102A2	108.56	13.57	6.79	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	97.84	44.82	6.31	1.89	1.26	0.63	1.26
small cell cervical cancer cell line:HCSC-1	10800-110I8	89.05	84.05	5.00	1.00	0.00	2.67	0.67
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	98.34	97.71	11.03	1.26	0.32	2.21	0.95
small cell lung carcinoma cell line:DMS 144	10841-111E4	118.15	56.09	4.43	0.96	0.58	1.35	0.19
small cell lung carcinoma cell line:LK-2	10541-107H1	95.76	78.62	8.24	1.32	1.32	4.62	0.00
small cell lung carcinoma cell line:NCI-H82	10842-111E5	85.41	106.48	9.81	0.32	0.64	8.20	0.48
small cell lung carcinoma cell line:WA-hT	10562-108A4	91.09	100.46	21.36	1.74	1.09	0.65	0.65
small intestine, adult, pool1	10024-101D6	82.89	22.57	9.20	0.72	1.31	0.24	1.91
small intestine, fetal, donor1	10064-101I1	83.05	35.13	9.09	0.25	0.00	0.49	0.00
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	77.45	36.93	11.28	1.03	0.00	0.51	2.05
smooth muscle, adult, pool1	10048-101G3	56.60	22.23	4.14	0.26	0.00	0.00	1.03
somatostatinoma cell line:QGP-1	10781-110G7	163.22	42.08	6.16	0.54	0.54	1.07	0.00
spinal cord - adult, donor10196	10181-103D1	113.10	68.82	4.36	0.69	0.23	0.69	0.00
spinal cord, adult, donor10252	10159-103A6	84.37	89.50	6.31	0.39	0.79	1.18	0.00
spinal cord, adult, donor10258	10369-105F9	35.28	86.47	3.46	0.00	0.00	0.69	0.00
spinal cord, fetal, donor1	10056-101H2	97.57	40.25	6.71	0.61	0.61	0.61	2.44
spinal cord, newborn, donor10223	10359-105E8	66.59	92.30	4.59	1.84	0.92	0.92	0.00
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	61.98	19.86	2.54	0.60	0.15	0.45	0.15
spleen, adult, pool1	10025-101D7	61.57	27.20	5.73	0.99	0.66	0.11	1.21
spleen, fetal, pool1	10044-101F8	71.19	24.07	8.98	1.59	0.87	0.32	1.99
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	66.66	48.75	10.66	1.76	0.72	0.41	0.10
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	90.38	17.66	7.03	1.52	0.38	0.19	0.00
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	56.26	40.54	6.99	0.70	0.35	0.35	0.00
squamous cell carcinoma cell line:T3M-5	10616-108G4	123.93	21.50	21.11	1.95	3.52	0.39	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	76.77	58.76	10.81	1.35	0.79	0.34	0.23
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	127.93	55.07	12.71	0.42	0.00	1.69	0.42
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	100.69	52.88	8.46	0.85	1.27	0.00	0.00
stomach, fetal, donor1	10062-101H8	202.91	38.45	5.34	0.00	0.00	0.00	1.07
submaxillary gland, adult	10202-103F4	67.22	15.38	15.38	0.57	0.00	0.00	1.14
substantia nigra - adult, donor10196	10178-103C7	54.27	54.27	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	71.24	86.61	5.19	0.42	0.00	0.83	0.21
substantia nigra, adult, donor10258	10371-105G2	52.24	81.21	2.59	0.52	0.52	0.00	0.00
substantia nigra, newborn, donor10223	10358-105E7	72.78	101.75	5.65	1.41	0.71	1.41	0.71
synovial sarcoma cell line:HS-SY-II	10441-106E9	83.45	61.44	8.02	2.52	0.23	1.15	0.69
temporal lobe, adult, pool1	10031-101E4	66.63	48.83	4.58	1.02	0.34	0.08	0.42
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	143.17	84.76	2.85	4.27	0.00	1.42	0.71
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	72.96	67.25	3.96	0.44	0.44	0.44	0.44
tenocyte, donor1	11763-123H8	32.82	21.99	1.40	0.00	0.00	0.00	0.00
tenocyte, donor2	11765-123I1	21.36	16.40	1.14	0.38	0.00	0.00	0.38
tenocyte, donor3	11768-123I4	20.39	12.60	1.48	0.00	0.00	0.00	0.00
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	90.42	66.28	3.91	1.70	1.53	3.91	0.34
teratocarcinoma cell line:NCR-G1	10798-110I6	87.40	63.82	11.87	2.47	0.92	2.77	1.39
teratocarcinoma cell line:PA-1	10807-111A6	85.39	43.55	7.13	2.32	0.93	2.32	0.00
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	123.52	60.30	6.73	2.54	2.41	6.98	0.63
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	195.52	111.56	22.31	2.27	6.05	8.32	1.51
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	151.27	16.36	7.85	2.18	4.36	2.62	1.85
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	75.89	85.01	9.77	2.28	1.95	6.19	0.00
testis, adult, pool1	10026-101D8	146.24	44.67	16.32	9.66	13.74	0.11	3.76
testis, adult, pool2	10096-102C6	303.13	117.28	17.14	13.08	4.06	1.35	8.57
thalamus - adult, donor10196	10168-103B6	88.32	97.15	3.31	2.21	2.21	1.10	0.00
thalamus, adult, donor10252	10154-103A1	84.24	86.58	5.47	0.16	0.16	0.78	0.16
thalamus, adult, donor10258, tech_rep1	10370-105G1	46.19	147.80	3.08	0.00	3.08	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	70.65	50.07	2.14	0.49	0.16	0.33	0.16
thalamus, newborn, donor10223	10366-105F6	56.96	50.05	4.60	1.73	0.58	0.00	1.15
throat, adult	10209-103G2	55.68	9.49	6.49	0.25	0.25	0.00	0.75
throat, fetal, donor1	10061-101H7	78.31	11.58	4.27	0.91	0.00	0.61	0.00
thymic carcinoma cell line:Ty-82	10803-111A2	99.56	92.81	7.15	0.79	0.40	0.79	0.40
thymus, adult, pool1	10027-101D9	106.18	81.62	14.51	4.27	3.48	1.99	1.89
thymus, fetal, pool1	10043-101F7	128.43	60.58	17.14	3.53	2.60	0.52	4.26
thyroid carcinoma cell line:KHM-5M	10776-110G2	48.53	18.08	6.91	0.93	0.93	1.20	0.27
thyroid carcinoma cell line:TCO-1	10783-110G9	80.46	24.45	4.89	0.42	0.28	0.42	0.28
thyroid, adult, pool1	10028-101E1	63.73	26.69	4.39	0.65	0.93	0.19	1.31
thyroid, fetal, donor1	10060-101H6	130.25	41.92	10.81	1.58	0.26	0.26	0.53
tongue epidermis (fungiform papillae), donor1	10288-104F9	160.14	33.88	12.32	0.00	0.00	0.00	0.00
tongue, adult	10203-103F5	43.49	21.63	4.88	0.93	0.00	0.00	0.70
tongue, fetal, donor1	10059-101H5	57.54	58.72	3.94	0.39	0.00	1.18	0.00
tonsil, adult, pool1	10047-101G2	80.34	28.45	13.22	1.40	0.90	0.30	1.20
trachea, adult, pool1	10029-101E2	54.48	22.82	6.38	0.25	1.15	0.00	0.98
trachea, fetal, donor1	10058-101H4	77.32	25.77	5.39	0.38	1.15	0.00	1.92
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	56.68	23.38	2.83	0.35	0.71	0.35	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	43.57	28.27	9.22	1.32	0.91	0.20	0.20
transitional-cell carcinoma cell line:JMSU1	10492-107B6	103.57	35.41	10.65	3.29	1.25	0.78	1.88
tridermal teratoma cell line:HGRT	10694-109G1	119.86	34.25	1.90	0.00	0.00	1.90	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	71.02	25.65	2.37	1.10	0.42	0.08	0.34
umbilical cord, fetal, donor1	10057-101H3	52.16	29.21	6.26	0.00	0.00	0.00	0.00
uterus, adult, pool1	10100-102D1	69.10	35.66	7.17	0.17	0.17	0.34	0.51
uterus, fetal, donor1	10055-101H1	74.23	48.12	7.17	0.51	0.00	0.00	0.51
vagina, adult	10204-103F6	107.92	33.60	3.23	0.65	0.65	0.00	0.00
vein, adult	10191-103E2	72.12	22.58	8.55	1.97	1.32	0.22	0.44
xeroderma pigentosum b cell line:XPL 17	10563-108A5	57.68	22.43	5.34	1.34	0.00	0.27	0.27

Property "Nearest transcripts" (as page type) with input value "ENST00000570200.5:-99 BC082760:-99 ENST00000562867.5:121 ENST00000564304.5:-256 BC144269:-256 BC136584:-256 ENST00000325215.10:-258 ENST00000382686.8:-258 ENST00000395547.6:-258 AJ317972:-258 AJ317971:-258 AJ317970:-258 AJ317973:-258 AJ317974:-258 BC068012:-275 ENST00000340394.12:-303 AK289981:-303 ENST00000563314.5:-316 ENST00000336783.9:-352 NM_001387203.1:-352 NM_001387199.1:-352 NM_001387187.1:-352 NM_001387202.1:-352 NM_001387185.1:-352 NM_001387179.1:-352 NM_001387188.1:-352 NM_001387186.1:-352 NM_001387180.1:-352 NM_001387204.1:-352 NM_148416.3:-352 NM_148415.3:-352 NM_001387195.1:-352 NM_001387198.1:-352 NM_001387196.1:-352 NM_001387177.1:-352 NM_001387175.1:-352 NM_001387176.1:-352 NM_001387174.1:-352 NM_145714.3:-352 NM_017492.4:-352 NM_001387167.1:-352 NM_001387168.1:-352 NM_148414.3:-352 NM_007245.4:-352 NM_001387191.1:-352 NM_001387192.1:-352 NM_001387194.1:-352 NM_001387173.1:-352 NM_001387184.1:-352 NM_001387183.1:-352 NM_001387178.1:-352 NM_001387200.1:-352 NM_001387197.1:-352 NM_001387190.1:-352 NM_001387189.1:-352 NM_001387193.1:-352 NM_001387170.1:-352 NM_001387169.1:-352 NM_001387182.1:-352 NM_001308230.2:-352 NM_001387166.1:-352 NM_001387172.1:-352 NM_001387181.1:-352 NM_001387171.1:-352" contains invalid characters or is incomplete and therefore can cause unexpected results during a query or annotation process.